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Abstract 
Background 
Poor adherence to lifestyle interventions and medication-taking poses a problem 
universally.  However, there are interventions to help patients adhere to treatment 
regimens and in turn, lower the risk of cardiovascular disease by decreasing blood 
pressure.  These interventions need to be investigated further.  Change in risk factors as a 
result of a lifestyle modification adherence tool in patients with chronic hypertension is 
not clear and will be further investigated in this study. 
Aim 
To determine the effect of a lifestyle modification adherence tool in patients with chronic 
hypertension and compare this with usual management. 
Objectives 
1.  To compare the changes in: 
• Blood pressure 
• Waist-hip ratio 
• Weight and body mass index 
• Blood glucose, cholesterol, triglycerides, HDL and LDL levels 
• Exercise Capacity 
between two experimental and one control group at baseline and after a six month 
intervention using a lifestyle modification tool 
2.  To determine the sustainability of the intervention three months after the intervention                                                                      
is concluded. 
 
 iii 
Design 
The study design was a quantitative, longitudinal randomized control trial consisting of 
two experimental and one control group. 
Method 
Ninety subjects at the hypertension clinic at Helen Joseph Hospital were sampled 
consecutively and then randomized using computer generated randomization and 
concealed allocation. 
The study consisted of three groups, two experimental and one control group. 
All three groups underwent the usual treatment in the Hypertension Clinic.  Experimental 
group one (EG1) received the Lifestyle Modification Adherence Tool (LMAT) as well as 
a once-a-month telephone call from the research assistant.  Experimental group two 
(EG2) received only a once-a-month telephone call from the research assistant.  The 
control group (CG) received the standard treatment at the clinic.   
The significance of the study was set at p=0.05.  A Students t-test (independent) was used 
to compare variables between groups at baseline.  The Pearsons Chi Square test was used 
to compare and analyze non parametric data at baseline.   
Change in blood pressure, waist-hip ratio, weight and body mass index, glucose levels 
and exercise capacity between control and intervention groups was established using an 
ANCOVA.   
Pairwise t-tests were used to compare p-values between groups one and two; one and 
three and; two and three. 
 
 
 
 
 iv
Results 
No reductions in weight and body mass index (BMI) were observed.  Significant 
differences in EG1 for waist/hip ratios were noted compared with the EG2 (p=0.04) and 
CG (p=0.04) between month 0 and month 6.  Blood pressure reductions were greater in 
EG1 compared with EG2 and the CG at six months but greater drops in blood pressure 
were noted in EG2 compared with EG1 and the CG between six and nine months.  
However, these differences were not significant.  Significant reductions were observed in 
blood glucose levels in the EG1 compared with EG2 group between month 6 and month 
9 (p=0.05).  There were also significant reductions in the EG2 in triglycerides and low 
density lipoprotein (LDL) between month 0 and month 6 compared with the CG (p= 0.04 
and p= 0.03 consecutively) and significant LDL reductions in both EG1 and EG2 
between month 6 and month 9 compared with the CG (p= 0.02 for both comparisons).  
Walking distances improved minimally in both EG1 and EG2 but these changes were not 
significant.      
Conclusion 
Although not all results were significant, diary and telephone interventions and telephone 
only intervention to improve adherence did show a positive trend towards improvements 
in risk factors of patients with chronic hypertension. 
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Chapter 1 – Introduction 
 
 
The management of hypertension has been widely researched throughout the world, 
especially in the last decade.  Many studies have shown ways to best prevent and reduce 
the complications of untreated hypertension (JNC-7, 2003, JNHGWG , 2006, Leenen et 
al, 2010, Appel et al, 2003, Ramsay et al, 1999 and Alhuwalia et al, 1997).  According to 
Miller et al (2002), hypertension, as a risk factor, is commonly associated with 
cardiovascular disease. 
 
In South Africa, a report by Professor Krisela Steyn (Department of Medicine, University 
of Cape Town) states that an average of 195 people died due to cardiovascular disease 
every day between 1997 and 2004, and that this figure is estimated to increase by 41% in 
35 – 64 year old people (working age) between 2007 and 2030 (Steyn, 2007).  Direct and 
indirect costs for cardiovascular disease and stroke are eight billion rand per annum 
(Mbewu, 2007).  Professor Mbewu also states that 80% of heart disease and stroke is 
preventable by adhering to healthy habits such as good diet, exercise and not smoking 
(www.medical.bizcommunity.com).  In many South African hospitals hypertension 
management guidelines are not adhered to resulting in poor blood pressure control 
(Stewart et al, 2005, Daniels et al, 2000 and Kalk et al, 2000).  In order to see effective 
changes in the management of patients with hypertension, we must find a way to enhance 
adherence to well researched regimens. 
 
Despite a large number of studies on patient adherence conducted during the past two and 
a half decades, the dilemma of adherence to hypertension regimens persists (Jokisalo et 
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al, 2002).  Studies show that adherence to lifestyle modifications and medication-taking 
in patients with chronic hypertension is problematic (Stewart et al, 2005, Gohar et al, 
2008).  Patient adherence is more than just adherence to medication prescription.   It can 
also include failure to keep appointments, exercise, adherence to recommended dietary or 
other lifestyle changes or other preventive health practices (Miller et al, 2002). 
The norm for adherence rates is about 50% for medications and is much lower for 
regimens that require lifestyle changes or changes in behaviour (Haynes et al, 2002).  
This leads to progressive disease and poor prognoses and therefore has implications for 
quality of life, lifespan and economic inefficiency (Neuhouser et al, 2002). 
There are many reasons for non-adherence to preventive and therapeutic lifestyle 
recommendations among patients at high risk of cardiovascular disease.  Patients’ main 
reasons for not adhering to lifestyle recommendations are unwillingness, difficulty 
adhering to diets different from the rest of the family, lack of time for exercise, other 
illnesses and unfavourable weather conditions (Serour et al, 2007). 
Two lifestyle factors shown to effectively reduce blood pressure include exercise and diet 
(Miller et al, 2002).  For example, there is much evidence showing that the risk of long 
term disease and co-morbid conditions will decrease when adhering to nutritional 
recommendations (e.g., low fat, high fruit and vegetable diet) provided that the disease or 
condition is modifiable by diet (Krauss et al, 2000).  Forty two percent of all adults in a 
nationally conducted study who reported a history of diabetes, cardiovascular disease, 
dyslipidemia or hypertension had poor diets and were not exercising regularly 
(Neuhouser et al, 2002).  
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Communication is very important in assisting patients to adhere to treatment regimens.  
Information about hypertension and the treatment thereof determines patient motivation 
and understanding.  This gives the patient purpose and helps them to see the importance 
of adherence to treatment (Jokisalo et al, 2002).  
There are very few studies demonstrating effective long-term adherence to medications 
and behaviour change.  Therefore, new strategies are needed to identify successful 
methods to help patients adopt and maintain healthy practices (Munro et al 2007, Atreja 
et al 2005 and Haynes et al, 2002).  
Methods to implement and sustain adherence must ensure that patients’ overestimation of 
adherence does not occur.  Reasons for overestimation can include patients’ difficulty 
with remembering the details of when and how to take medication and also that they 
prefer to please practitioners and therefore want to avoid confrontation with health 
workers (Haynes et al, 2002).   
 Treatment regimens that are very complex will affect adherence and must be kept as 
simple and clear as possible if adherence is likely to be achieved.  It is important to 
remind patients of their appointments by phoning patients who have missed appointments 
to ensure optimal follow-up and re-iterating the importance of adherence every time 
patients visit an institution.  Health care professionals must use these methods to monitor 
adherence to treatment regimens as they improve effectiveness, practicality and 
efficiency of patient care.  It may also be important to get the family involved for extra 
support, if the patient consents to this (Miller et al, 2002 and Stewart et al, 2005).  
Heneghan et al (2006) also emphasized how reminder packing of medications is a simple 
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and effective way of improving adherence to treatment regimens.  Therefore, for both 
lifestyle modification and medication-taking, regimens should be practical and fit in with 
the patient’s normal daily activities (Miller et al 2002). 
There are minimal studies on sustaining lifestyle modification behaviours, indicating a 
great need for further research in this area (Moore et al, 2008).  It is important to note that 
if patients see their adherence to regimes is time- and money-saving and is largely 
beneficial, this may help sustain adherence and improve prolonged lifestyle modification 
(Brunenberg et al, 2007). 
In conclusion, health care professionals often underestimate the problem of non-
adherence in their patients.   If a healthcare professional is unable to detect non-
adherence, it is impossible for him or her to correct the problem. Measurement of 
adherence is an important part of assessing the effectiveness of interventions (Miller et al, 
2002).   From previous studies, we already know that for hypertensive overweight adults 
already on antihypertensive medication, a comprehensive lifestyle intervention can 
substantially lower blood pressure and improve blood pressure control (Heneghan et al, 
2006).  However, as mentioned above, further research is necessary to develop methods 
to help patients adopt and maintain these lifestyle interventions.   
Problem Statement  
Poor adherence to lifestyle interventions and medication-taking poses a problem 
universally.  However, there are interventions to help patients adhere to treatment 
regimens and in turn, lower the risk of cardiovascular disease by decreasing blood 
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pressure.  These interventions need to be investigated further.  Change in risk factors as a 
result of a lifestyle modification adherence tool in patients with chronic hypertension is 
not clear and will be further investigated in this study. 
 
Question 
What is the effect of a lifestyle modification adherence tool on risk factors in patients 
with chronic hypertension compared to usual management? 
 
Aim 
To determine the effect of a lifestyle modification adherence tool in patients with chronic 
hypertension and compare this with usual management. 
 
Objectives 
1.  To compare the changes in: 
• Blood pressure 
• Waist-hip ratio 
• Weight and body mass index 
• Blood glucose, cholesterol, triglycerides, high density lipoprotein (HDL) and low 
density lipoprotein (LDL) levels 
• Exercise Capacity 
between two experimental and one control group at baseline and after a six month 
intervention using a lifestyle modification tool 
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2.  To determine the sustainability of the intervention three months after the intervention                                                                      
is concluded. 
 
Hypothesis Statement 
H0:  There will be no change in risk factors as a result of this intervention. 
H1:  There will be a change in risk factors as a result of this intervention. 
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Chapter 2 – Literature review 
 
2.1 Introduction 
This review includes an understanding of adherence and how we can improve adherence 
to hypertension regimens.  This is achieved by first discussing the prevalence of 
hypertension both internationally and locally; gaining an understanding of how it is 
presently controlled and discussing which factors affect the adherence to such regimens.   
 
2.2 Epidemiology 
2.2.1 Definition of hypertension 
Hypertension is defined according to the World Health Organization-International 
Society for Hypertension as being a blood pressure greater than or equal to 140/90mmHg 
(Guidelines Subcommittee, 1999).  The South African Hypertension Guideline 2003 
update (Milne and Pinkney Atkinson, 2004) describes that changing the definition of 
hypertension from 165/95mmHg to 140/90mmHg has resulted in another three million 
individuals being added to the hypertension population and that this has huge 
consequences regarding the available resources for hypertension care in South Africa 
(WHO, 2005).  The South African Hypertension Guidelines 2006 use the internationally 
accepted definition of hypertension as a blood pressure greater than or equal to 
140/90mmHg (JNHGWG, 2006) 
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2.2.2 Global statistics 
Universally, hypertension causes approximately 7.1 million deaths per annum and its 
prevalence is 950 million people globally (Lawes et al, 2004 and Seedat, 2007).    It was 
estimated that by 2010, 1.2 billion people would be suffering with hypertension 
worldwide (WHO, 2005).   
Hypertension is associated with cardiovascular disease (CVD) which, according to WHO 
(2005), is the world’s number one cause of death for 17 million people each year.  
Globally, 60% of CVD load and approximately 50% of coronary heart disease is due to 
hypertension (Seedat, 2007). Overweight and obesity also contribute as risk factors and 
according to WHO (2005), 1.6 billion people are overweight and 400 million adults are 
obese globally (risk factors will be discussed in section 2.3).  WHO (2005) also states 
that this is due to factors such as globalization, urbanization and population ageing as 
well as poverty and stress (also discussed later).   
 
2.2.3 Sub-Saharan statistics 
Hypertensive induced morbidity and mortality is increasing in sub-Saharan Africa.  In 
2000, hypertension in Sub-Saharan Africa accounted for 41.6 million males and 38.2 
million females (Seedat, 2007).  In sub-Saharan Africa, blood pressure control and 
prevention is largely hindered by lack of resources, economic pressure, poor healthcare 
systems, inaccessibility to appropriate medications and unhealthy behaviours (Seedat, 
2007).  Implementation of appropriate lifestyle interventions and cost-effective methods 
of providing quality care and resources to impoverished and under-developed areas will 
help in attaining better blood pressure control for patients with hypertension (Mensah, 
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2008) as long term drug therapy is not affordable for every hypertensive patient (Seedat, 
2007).   
 
2.2.4 South African statistics 
The Demographic and Health Survey on Hypertension in South African adults by Steyn 
et al. (2001) shows that 21% of South Africans are hypertensive (Rayner and Schoeman, 
2009 and Steyn et al, 2001).  Data received from registers in Gauteng’s four largest 
hospitals showed that hypertension is the sixth most frequently diagnosed condition.  
Although this information was only taken from four hospitals, it is also important to state 
that hypertension is often “under-diagnosed and under-reported” (GDoH, 2007).  This 
report also states that, in Gauteng, hypertensive heart disease is the 17th single cause of 
mortality in males and the eighth single cause of mortality in females (GDoH, 2007). 
Steyn et al (2001) state that the proportion of patients with hypertension who are 
receiving treatment and controlling their hypertension is 67%.  This figure may not be 
accurate though, as only patients producing medicine containers were counted as 
receiving treatment which exaggerates their level of control.  It is important to find ways 
to treat this major problem in South Africa through lifestyle modification and other non-
pharmacological and cost-effective ways in order to decrease morbidity and mortality 
resulting from ineffective treatment of hypertension (Steyn et al, 2001).  A study by 
Steyn et al (2008) determined which specific groups of people are at higher risk for 
hypertension and poor blood pressure control in South Africa (discussed below).   
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2.2.4.1 Gender statistics 
Hypertension rates in men and women are 20.9% and 21.2% respectively (age-adjusted 
rates to South African population).  It was also shown that women were more aware of 
their condition than men, and a higher percentage of women than men were being treated 
with antihypertensive medications.  Women were also shown to control their blood 
pressure better than men (Steyn et al, 2001).  Men who are 45 years and younger are 
poorly aware of hypertension control and treatment and they seldom attend health 
institutions (Steyn et al, 2001). 
 
2.2.4.2 Rural vs. Westernization statistics 
Steyn et al (2001) state that almost 50% of the population in 2001 was rural but with 
westernization of the black population, hypertension prevalence rates are expected to 
increase with time.     
Rural black people have a lower prevalence of hypertension compared to urban black 
people (Steyn et al 2008, 1991 and Seedat, 2009, 2007, 1982).  This is due to 
westernization of black people which was seen first and more often in men as women 
were confined to rural areas for much longer.  Rural black men were therefore exposed to 
urban areas earlier resulting in them adopting poor eating habits and becoming less 
physically active.  Therefore western lifestyle habits have been shown to predispose the 
black population to hypertension (Steyn et al 2008, 1991 and Seedat, 2009, 2007, 1982).   
In a study on a Zulu population a higher prevalence of hypertension was found in urban 
as opposed to rural Zulus.  This may be due to urban Zulus being more exposed to factors 
commonly associated with hypertension such as poorer and more stressful lifestyles 
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(many children to support and unfavourable working environments) and habits such as 
smoking and alcohol consumption (Seedat 2009, 2007, 1982). 
 
2.2.4.3 Poverty vs. wealth statistics 
Wealthier groups have a higher prevalence of hypertension but are able to control it better 
than poorer groups with hypertension (Steyn et al, 2008).  The literature also shows that 
in populations which are disadvantaged, the prevalence of hypertension and 
cardiovascular disease is higher (Ahluwalia et al, 1997 and Seedat, 2007).  Over 80% of 
CVD deaths worldwide have occurred in middle to low income countries (Seedat, 2007).  
In South Africa, high unemployment rates are linked with poverty, lack of education, 
stress, family difficulties and obesity (Stewart et al, 2005).  Higher education is 
associated with lower prevalence of hypertension (Steyn et al, 2008).  It is also noted that 
patients with hypertension on medical aids are more likely to control blood pressure 
better than those who are utilizing public services.  This may not necessarily be due to 
poor adherence but largely due to the lack of appropriate service delivery to these patients 
(Steyn et al, 2008).   
 
2.2.4.4 Age statistics 
Older groups are more adherent in controlling blood pressure and taking medications 
regularly than younger groups.  This is of great concern as younger individuals exposed 
to hypertension for longer develop associated complications such as eye and kidney 
damage amongst other complications (Steyn et al, 2008).   
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The burden of hypertension not only in our country but around the globe brings us to 
question why it is so highly prevalent and difficult to control.  It is therefore important to 
discuss factors affecting the control of high blood pressure. 
 
2.3 The risk factors for the development of hypertension and CVD  
Lifestyle modification becomes an important treatment alternative where the risk of 
developing hypertension is lower or even in conjunction with antihypertensive 
medication.  A recent study by Murray et al (2003) highlights the importance of lifestyle 
and drug therapy in lowering the risk of CVD by as much as 50% in both developed and 
underdeveloped regions.   
Lack of physical activity, obesity, excessive alcohol consumption and an incorrect diet 
(high sodium and fat content) contribute to hypertension and CVD (JNC-7, 2003, 
JNHGWG, 2006, Appel et al, 2003, Ramsay et al, 1999 and Steyn, 2008).     
Some of the major risk factors for hypertension include:   
 
 2.3.1 Smoking 
Smoking is a major risk factor in the development of cardiovascular disease and 
development of hypertension (JNHGWG, 2006).   
 
2.3.2 Dyslipidaemia 
Total cholesterol greater than 6.5mmol/l; low density lipoprotein greater than 4mmol/l or; 
high density lipoprotein less than 1mmol/l in men and less than 1.2mmol/l in women are 
major risk factors in the development of cardiovascular disease (JNHGWG, 2006). 
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2.3.3 Diabetes 
Diabetes mellitus in men older than 55 years and women older than 65 years of age 
increases the risk of cardiovascular disease in hypertension (JNHGWG, 2006). 
 
2.3.4 Positive family history of early onset of cardiovascular disease 
The risk of cardiovascular disease is elevated in men younger than 55 years and women 
younger than 65 years of age where there is a positive family history of early onset of 
cardiovascular disease (JNHGWG, 2006). 
 
2.3.5 Abdominal obesity 
Waist circumference should be less than or equal to 102cm in men and less than or equal 
to 88cm in women.  Obesity is associated with a noticeably high occurrence of 
hypertension (Leenen et al, 2010).  By introducing ways to decrease obesity in 
hypertensive patients, we will also reduce the prevalence of hypertension.   
 
When looking at the risk factors for hypertension, it is necessary to immediately initiate 
treatment of patients with CVD, target organ damage (TOD) and those with systolic 
blood pressure (SBP) greater than or equal to 180mmHg or diastolic blood pressure 
(DBP) greater than or equal to 110mmHg.  However, in the absence of TOD and 
associated clinical conditions, the level of blood pressure at which to begin medication 
treatment is debatable. (JNHGWG, 2006).  Refer to Appendix G for further 
understanding of risk stratification (JNHGWG, 2006). 
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2.4 The control of blood pressure 
In 2000 in South Africa only 7% of black males and 15% of black females with 
hypertension had controlled blood pressure (Seedat, 2007 and Steyn et al, 2001).  It is 
difficult to control blood pressure in patients who have already been diagnosed with 
hypertension (Alhuwalia et al, 1997).  This may be because patients who have been 
taking antihypertensive medications chronically and attending clinics for long may have 
reached a certain blood pressure level already, whereas patients who are newly diagnosed 
may achieve better blood pressure control with interventions other than medication-
taking (Stewart et al, 2005).  Patients know whether their blood pressure is high, normal 
or low, but still knowledge of their diagnosis and medication alone does not appear 
sufficient in controlling blood pressure (Alhuwalia et al, 1997).  Methods to control blood 
pressure will be discussed below in detail. 
 
2.4.1 The South African Hypertension Guideline 2006 
2.4.1.1 Objective 
The objective of the South African Hypertension Guideline 2006 is to provide an 
accessible, evidence-based and holistic approach to the management of hypertension in 
both private and public sectors (JNHGWG, 2006).   
 
2.4.1.2 Blood pressure measurement 
Blood pressure measurement must be accurately performed.  Despite the importance of 
performing this task, many health care professionals do not measure blood pressure 
correctly (JNHGWG, 2006). 
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2.4.1.3 Sustainable management of hypertension 
The Department of Health and the South African Hypertension Society find it 
unacceptable that many patients are suffering with the consequences of poorly managed 
hypertension (JNHGWG, 2006).  Medication-taking and lifestyle modification are two 
cost-effective ways to control hypertension (Murray et al, 2003 and JNHGWG, 2006). 
Lifestyle modification should be initiated with every hypertensive patient immediately.  
This is discussed below under section 2.4.2. 
 
2.4.1.4 Patient education 
The South African Hypertension Guideline 2006 emphasizes the importance of educating 
the patient and communicating effectively with the patient.  Patients must experience a 
mutual relationship which will allow them to become actively involved in the 
management of their condition (JNHGWG, 2006).  However, this is discussed later with 
factors affecting adherence to treatment regimes. 
 
2.4.2 Control in specific risk factors 
2.4.2.1 Body mass index 
The BMI must be maintained between 18.5 and 24.9kg/m².  Similarly, the JNC-7 (2003) 
states that management guidelines in terms of lifestyle modification include maintaining 
a BMI (body mass index) of <25 or reducing a BMI of >25 in obese patients (JNC7, 
2003). 
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2.4.2.2 Salt intake 
Sodium intake should be less than 2400mg per day (equivalent to less than one teaspoon 
of salt).  Processed and tinned foods, amongst others, are high in sodium content and 
should be avoided.  Salt intake should be limited by removing salt from the table or 
reducing salt use when cooking (JNC7, 2003, Appel et al 2003 and JNHGWG, 2006).  
The use of lemon juice and herbs is encouraged in order to make food tastier (JNHGWG, 
2006). 
 
2.4.2.3 Alcohol consumption 
Alcohol intake should be reduced to no more than two units per day (JNC7, 2003 and 
Maheswaran et al, 1992).  More specifically, only two units per day for men and one unit 
per day for women and small men (JNHGWG, 2006). 
 
2.4.2.4 Smoking 
Smoking has been associated with increased prevalence of microalbuminuria, defined as 
a urinary albumin excretion of 30-300mg/day (Ukena et al, 2010).  Microalbuminuria is 
an indicator of systemic vascular damage (Gerstein et al, 2001). Ceasing to smoke or use 
any tobacco product is necessary as it lowers the risk of microalbuminuria (Ukena et al, 
2010).  Replacement therapy is available if needed (JNHGWG, 2006 and JNC-7, 2003). 
 
2.4.2.5 Exercise 
A meta-analysis shows that progressive resistance exercise is efficient in slightly 
reducing both systolic and diastolic resting blood pressure (Kelley et al, 2000) and 
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another meta-analysis shows that aerobic exercise lowers blood pressure (Whelton et al, 
2002).  Exercising regularly (3-5 times per week for at least 30min per session) will 
reduce risk of developing hypertension and CVD (JNC7, 2003 and Appel et al 2003).  
Moderate intensity exercise (40% - 60% of peak oxygen consumption) is sufficient and 
exercise may be continuous or occur in bouts throughout the day.  The effects of exercise 
are most beneficial and effective when begun after not exercising at all.  However, 
exercise should not be initiated until after initial consultation and treatment has taken 
place (JNHGWG, 2006). 
 
2.4.2.6 Diet 
The “Dietary Approach to Stop Hypertension” (DASH) diet has been shown to be 
effective and is critical in preventing high blood pressure (Milne and Pinkney Atkinson, 
2004, JNHGWG, 2006, Sacks et al, 2001, Appel et al 2003 and JNC-7, 2003).  The 
DASH principles include increasing fruit and vegetables and low fat dairy products; and 
high-fibre wholegrain products, poultry, fish and nuts; reduce salt, sugary foods and 
beverages, saturated fat and red meat and only 1-2 beverages per day containing caffeine 
(Miller et al, 2002).   
 
2.4.3 Difficulties in controlling hypertension 
2.4.3.1 Non adherence to Hypertension Guidelines 
A cross-sectional study by Rayner and Schoeman (2009) discussed the reasons for poor 
blood pressure control by selecting patients with hypertension from 15 selected general 
practices throughout South Africa.  Although complex, one reason for poor blood 
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pressure control may be due to physicians not managing patients with high blood 
pressure according to the hypertension guidelines despite awareness of persistently raised 
blood pressure.  The study shows that 61.2% of patients with hypertension achieved 
blood pressure control below 140/90 mmHg.  However, according to the hypertension 
guidelines a better target for patients with high cardiovascular risk is less than or equal to 
130/80 mmHg (JNHGWG, 2006).  The Hypertension Guidelines have been discussed in 
detail above. 
 
2.4.3.2 Management of health care service 
 A major factor in controlling blood pressure is attributed to the care provided by the 
health professional and the structures in place to allow optimal care.  In Africa, due to 
social difficulties and poverty, poor detection and control of hypertension is evident 
(Seedat, 2007).  In public health institutions in South Africa, both human and material 
resources are limited. There is high turnover of staff which disrupts continuity of care 
(Katz et al, 2009 and Steyn et al, 2008).     
Studies have shown that frequent visits to healthcare providers do not necessarily 
improve blood pressure control (Hyman et al, 2001 and Berlowitz et al, 1998) and that 
clinical inertia may contribute to poor blood pressure control (Phillips et al, 2001).   
Clinical inertia is defined by Phillips et al (2001) as the ineffective implementation of 
effectively researched and useful practices into the clinical setting – “recognition of the 
problem, but failure to act” (Phillips et al, 2001).  A reason for clinical inertia may 
include health care practitioners’ overestimation of the care they provide (Phillips et al, 
2001) when they are not practicing in accordance with hypertension guidelines (Hyman 
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et al, 2000).  This is shown to be true in South African hospitals too (Daniels et al, 2000 
and Southern African Hypertension Society Executive Committee, 2000).  This 
difference between evidence-based practice and actual practice may be due to 
practitioners not possessing adequate educational knowledge, training or background in 
order to be effective in making clinical decisions (Phillips et al, 2001 and Katz et al, 
2009) or not having the means to manage patients effectively (Katz et al, 2009).  In a 
study by Katz et al (2009), a Chronic Disease Outreach Programme was used to improve 
the health care structures and provide support to primary health care nurses in and 
surrounding Soweto.  The programme enabled early detection of patients with chronic 
disease and in supporting nurses- therefore improving risk factor control.  However, it 
was limited by resources and poor follow-up.  The health team felt frustrated, 
overworked and underpaid.  Within the health care team there was a high turnover of 
staff who were generally poorly educated concerning chronic disease (Katz et al, 2009).  
Limited resources within the public healthcare system were also acknowledged in another 
study done in a South African hospital but there are ways to manage patients by 
designing a programme which takes this limitation into account (Stewart et al, 2005).  
This programme involves including healthcare practitioner and a family member through 
telephonic intervention, in conjunction with exercise and education (Stewart et al, 2005).  
This will be discussed in more detail later. 
 
2.4.3.3 Misinterpretations by health care practitioners 
Poor blood pressure control is often treated by changing medications or dosages of 
medications when the underlying problem is really poor adherence to regimens.  This is 
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expensive and fruitless as patients’ blood pressure will not improve if they are not taking 
their prescribed medicines (Heisler et al, 2008).  This study shows that health 
professionals’ decisions to intensify medications was hardly affected by whether patients 
were adherent to their blood pressure medications or not.  This may be due to time 
limitations or lack of equipment in the form of an electronic medical record programme 
in clinics or institutions.   
 
2.4.3.4 Health belief model 
One patient-centred approach involves the Health Belief Model which suggests that a 
person takes actions regarding their health by firstly, depending on how susceptible they 
feel towards an illness; secondly, depending on how severe they perceive the illness is; 
thirdly, whether the suggested action is beneficial for them and lastly, a prompting should 
occur to trigger the health behaviour (King, 1982).  An older study shows the effects of 
health belief on adherence to treatment for hypertension.  In this study, patients who 
found it easier to comply with the regimens and who felt more independent and in control 
adhered better to treatment (Kirscht and Rosenstock, 1977).   
 
In order for change to take place, Miller et al (2002) and Atreja et al (2005) state that the 
patient must feel at risk by not modifying behaviour (perceived susceptibility), feel that 
the condition is of great importance (perceived severity), feel they will improve if they 
adopt the behaviour (perceived benefits), possess ways in which they might overcome the 
negativity of the condition (perceived barriers) and feel they have the necessary ability to 
make the positive change (self-efficacy) (King, 1982). 
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Participation and support of patients in research studies creates feelings of positivity 
toward health behaviour change (Cohen et al, 2005).  Further research is needed to 
identify what motivates patients to participate in research but some reasons may include 
good communication, perceived benefit from participation and their interest in the subject 
being researched (Raftery et al, 2008).   
 
2.4.4 Potentially effective programmes 
2.4.4.1 Preventative measures 
Strategies to improve and prevent CVD and therefore reduce hypertension in Sub-
Saharan Africa include improving incentives and recognition of health care workers and 
to engage them in preventative measures and educational programmes and for health care 
workers to realize the value of cost effectiveness therein (Seedat, 2007 and Bosworth, 
2008).  These strategies seem difficult to achieve in South Africa but involvement of 
political leaders and mass media may assist in initiating such strategies (Seedat, 2007).  
However, education on its own is not shown to improve the control of blood pressure and 
must be used in conjunction with programmes described below (Glynn et al, 2010, 
Hennessy et al, 2006 and Márquez Contreras et al, 2005). 
Heisler et al (2008) suggest equipment in the form of electronic data linking to patient 
biomedical data to proactively identify patients with poor blood pressure control (Heisler 
et al, 2008).  However, this may not be feasible in South African public hospitals due to 
lack of budget available to implement and maintain such equipment. 
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2.4.4.2 Management according to Hypertension Guidelines 
In order to improve control of blood pressure, treatment should be compatible with 
hypertension guidelines in that a stepped approach to anti-hypertensive medication is 
administered in conjunction with risk reduction (Glynn et al, 2010, Hennessy et al, 2006 
and Márquez Contreras, 2005).  The results of not treating according to hypertension 
guidelines is clinical inertia (discussed above) and it has been shown to occur in South 
African hospitals (Stewart et al, 2005, Hyman et al, 2000, Philips et al, 2001, Daniels et 
al, 2000 and Southern African Hypertension Society Executive Committee, 2000) 
 
2.4.4.3 Lifestyle modifications 
According to the South African Health Review 2005, lifestyle diseases were responsible 
for 38% of all deaths in South Africa (Seedat, 2007 and Health Systems Trust, 2006).  
Lifestyle modification in conjunction with appropriate medication dosages is necessary to 
create a comprehensive and optimal programme to achieve blood pressure control and in 
turn, lower cardiovascular morbidity and mortality (Rayner and Schoeman, 2009 
Bosworth et al, 2008 and Cobb et al, 2006).  Other studies show that methods to 
encourage lifestyle modification as discussed under section 2.4.2 are beneficial in 
assisting to gain blood pressure control (Glynn et al, 2010, Hennessy et al, 2006 and 
Márquez Contreras, 2005).  Health professionals must understand and address lifestyle 
behaviour modification and pharmacology in order to gain effective blood pressure 
control (Heisler et al, 2008, JNC-7, 2003 and JNHGWG, 2006).   
Effective blood pressure control can be implemented only if patients are willing to adhere 
to treatment regimes and modify lifestyle in terms of exercising regularly, eating 
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correctly, taking medicines as prescribed and reducing alcohol consumption where 
necessary (Maheswaran et al, 1992).   
 
2.4.4.4 Reminders 
There should be follow-up to ensure lifestyle behaviour has commenced and is being 
sustained (Heisler et al, 2008, JNC-7, 2003 and JNHGWG, 2006).  Bosworth et al (2008) 
stated that enhancing blood pressure control needs to be methodically addressed by 
improving the ability to understand, remember and comprehend (Bosworth et al 2002, 
2005 and 2008).   
There are various methods of reminding patients to adhere to treatment regimens: 
 
• Telephonic reminders 
Positives of telephonic reminders 
Bosworth et al (2008) investigated an individually tailored behavioural intervention 
administered by a nurse via telephone.  Nurses used laymen’s term as opposed to medical 
terminology when conducting telephone calls and questions were tailored to suit the 
subject’s individual needs.  According to Bosworth et al (2008), this prevents 
unnecessary and irrelevant information being asked which is ultimately time-saving and 
cost-effective.  Although thought to be difficult to implement in South Africa due to 
language barriers, it has been found that most people do own cell phones and literature 
has shown that, in South Africa, telephonic and cell phone reminders assist in improving 
cardiovascular risk factor modification (Stewart et al, 2005).  Others studies also show 
that telephone and mail reminders assist in bettering patient adherence to hypertension 
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regimens (Márquez Contreras et al, 2005 and Stewart et al, 2005) and may improve blood 
pressure control (Márquez Contreras et al, 2005).   
Negatives of telephonic reminders 
When using telephonic reminders for research purposes, one limitation may include the 
unavoidable trust that must be placed on subjects to report back truthfully (Bosworth et 
al, 2008).  Telephonic reminders may take time if there are many patients to phone and 
thus requires commitment to carry them out (Márquez Contreras et al, 2005). 
 
• Internet and SMS reminders 
Positives of internet and SMS reminders 
Short message service (SMS) by cellular phones and web-based programmes have been 
shown to significantly lower blood pressure amongst other risk factors (Park et al, 2009).  
In this study, subjects in the intervention group underwent an eight week programme 
which included individually tailored lifestyle advice on exercise, diet, medication 
alteration and body mass levels.  Subjects were trained on how to enter their data on the 
internet which enabled them to send their self-assessed blood pressure, weight and 
medication alteration information to the researcher electronically.  This allowed the 
researcher to then respond to the subject with correction and further advice on how to 
modify behaviour accordingly.   
According to Park et al (2009), reasons for the reduction in blood pressure amongst other 
risk factors may include the regular communication with subjects and individually 
tailored programmes which may have motivated the subjects to more eagerly adhere to 
lifestyle modification.   
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Negatives of internet and SMS reminders 
The study did have some limitations and may not be applicable in all settings as many 
people do not have access to the internet (Park et al, 2009).  This may also be the case in 
South Africa where, due to poverty, lack of education and poor socio-economic status 
(Stewart et al, 2005 and Steyn et al, 2008) patients may not have access to the internet or 
even know how to make use of the internet. 
 
• Other reminder devices 
Microelectronic devices such as medication boxes and alarms help patients to remember 
to take their medicines.  These have been shown as effective measures to organize and 
improve adherence to treatment regimens (Shroeder et al, 2004 and Cramer, 1998) and 
are discussed under section 2.5.5.1. 
 
A recent review by Glynn et al (2010) stated that reminders, whether postal or electronic, 
were related to improved follow-up and control of patients with hypertension but not 
their blood pressures.  There are other studies which show that phone calls and reminders 
assist in improving adherence to treatment regimens. These studies indicate that both 
postal and telephonic appointment reminders are effective in overcoming missed 
appointments and these methods are relatively inexpensive (Haynes et al, 2002, Yusuf et 
al, 2000 and Macharia et al, 1992).  Telephonic reminders are shown to be slightly more 
effective than postal reminders (Márquez Contreras et al, 2005).  The telephonic reminder 
system will likely be more effective than the postal reminder system though such studies 
 26
have not been conducted in South Africa.  This is because many patients live in informal 
settlements and do not have access to a proper postal service.   
 
2.4.4.5 Patients ability and efforts 
Patients are also responsible for controlling their own blood pressure and they must be 
willing to adhere to treatment regimens in order for effective blood pressure control to 
occur.  (Maheswaran et al, 1992).  Despite the poor lifestyle of patients in South Africa, it 
is possible to change behaviour if the patient is willing to take responsibility for their own 
health (Stewart et al, 2005). 
 
2.5 Adherence to treatment regimes 
2.5.1 Definition of adherence 
Márquez Contrereas et al (2005) define adherence as “the degree to which patients follow 
the guidelines or instructions provided by the physician or health personnel in terms of 
the recommended lifestyle habits and prescribed drug treatment – with fully reasoned 
acceptance of such instructions on the part of the patient, i.e. without submissive 
connotations” (Márquez Contreras et al, 2005, page 151).  The term ‘adherence’ is used 
interchangeably with the term ‘compliance’ in the literature; however, compliance is 
more suggestive of the health professional making decisions as opposed to the term 
adherence, which suggests that the patient plays a role in the decision-making process 
(Lutfey et al, 1999).  Research shows that when patients are made aware of their non-
adherence and the consequences thereof, adherence improves (Burnier, 2000). 
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2.5.2 Medication adherence and lifestyle modification 
Adherence to prescribed medications is low but adherence to lifestyle modification is 
even lower (Haynes et al, 2002).  Other studies also show adherence to lifestyle 
modifications when compared to medication –taking in patients with chronic 
hypertension to be challenging (Gohar et al, 2008 and Miller et al, 2002).  This may be 
because it is much easier to take a tablet regularly than to change eating and exercise 
habits or to stop smoking.  However, this leads to poor disease outcomes and therefore 
has large implications for quality and length of life and financial implications (Marian et 
al, 2002).  Patient adherence includes behaviour modification and not just medication-
taking (Haynes et al, 2002, Gohar et al, 2008 and Miller et al, 2002) but behaviour 
modification is attainable and when used in conjunction with medication can help to 
lower cardiovascular risk factors (Sol et al, 2008 and Wadden, 2005).  Therefore, it is 
necessary to find ways to improve adherence to treatment regimens in order to improve 
blood pressure.  (Gohar et al, 2008).   
 
2.5.3 Lifestyle modification adherence 
As discussed under the section “the control of blood pressure”, health care professionals 
must use lifestyle modification methods such as the Dietary Approach to Stop 
Hypertension (DASH) diet, reduce sodium intake and exercise to monitor adherence to 
treatment regimens as they improve patient care (Miller et al, 2002). 
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2.5.3.1 Exercise 
Adherence to exercise is a problem and further research is needed to identify ways to 
improve adherence to exercise programmes (Whelton et al, 2002).  Significant decreases 
in systolic and diastolic blood pressure (amongst other risk factors) were observed in 
patients aged 50-65years when participating in an unsupervised home-based walking 
programme (Tully et al, 2005).  The programme consisted of a 30 minute, brisk walk five 
days a week and information on how much time was spent walking and how many steps 
were taken were recorded in a diary.  Tully et al (2005) comments on a report made just 
prior to this study by the Chief Medical Officer for England (2004) which stated that 
people find it very difficult to translate their exercise advice into a behaviour pattern to 
suit their lifestyle.  According to Tully et al (2005), adherence was 90.3%, which was 
measured as a percentage of the number of minutes walked in comparison to the number 
of minutes prescribed by the protocol.  This may be due to easily available resources and 
accessibility as well as being accustomed to the environment.  The subjects were also 
allowed to choose whether they would prefer to walk the entire 30 minutes or do several 
sessions to make up the 30 minutes.  The improved adherence to the home-based 
programme may be attributed to individualization of the programme to suit the subject’s 
daily lifestyle better.  No change was found in the control group.  This is supported by 
Burke et al (2009) who state that a tailored approach encourages a better patient-
practitioner relationship by taking into account the attitudes, preferences, goals and 
routines of individual patients.   
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2.5.3.2 Eating habits 
The literature shows that patients find it difficult to adhere to a diet different from the rest 
of the family and do not follow recommended dietary requirements such as the DASH 
diet described above (Serour et al, 2007 and Miller et al, 2002).  It is known that weight 
reduction due to poor eating habits and lack of exercise (discussed above) is immensely 
difficult to achieve and remains a large concern in patients with hypertension and 
cardiovascular disease (Frolich, 2002).  It is especially difficult to achieve good eating 
habits in South Africa due to poverty, poor knowledge of healthy eating habits, 
unemployment and difficulty maintaining healthy lifestyles in poor socio-economic areas 
(Stewart et al, 2005). 
 
2.5.4 Difficulties experienced with adherence to treatment regimes  
Enthusiasm and sustained adherence to a healthy lifestyle is challenging for patients 
(Cobb et al, 2006) and the literature provides a comprehensive view on why adherence is 
so difficult to achieve (discussed below). 
It is difficult and time consuming to achieve long term adherence but it is worthwhile and 
ultimately cost effective (Haynes et al, 2002) as is shown in one older article (Logan et al, 
1981) and may also be cost-effective for patients themselves (Brunenberg et al, 2007).  
For example, failure to exercise (Miller et al, 2002) or lack of time for exercise (Serour et 
al, 2007) affects adherence negatively, which in turn will result in further non-adherence.   
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2.5.4.1 Keeping appointments 
Patients who keep appointments and are motivated are more likely to adhere better to 
lifestyle modification.  Missing appointments is correlated with lower adherence rates to 
prescribed regimens (Gordis et al 1969, JNC7 2003 and Miller et al 2002).    A study by 
Saunders in 1983 included visits to the homes of 75 non-adherent patients between 18 
and 21 months after the patient’s first visit in order to establish why the patient had not 
returned for the next appointment. Five of the 75 (7%) had died, 16 (21%) were not 
available to converse and 54 (72%) were interviewed.  The most common reasons, 
according to the 54 interviewed, for not returning regularly included not remembering 
that they were told they have high blood pressure and must return (14 patients), they went 
away from home (7 patients), they could not get sick leave (6 patients), they felt they did 
attend regularly (5 patients) and they had unfavourable side effects from the drugs (4 
patients).  Two patients received regular treatment at another institution.    Earlier 
findings show that reminders are effective in helping patients adhere to appointments and 
ultimately improve blood pressure control (Haynes et al, 2002, Atreja et al, 2005, Yusuf 
et al, 2000, Macharia et al, 1992, Stewart et al 2005, Márquez Contreras et al, 2005, 
Khalil et al, 1997 and Miller et al, 2002). 
The complications of attending treatments and appointments can affect patients’ non 
adherence to therapy.  Difficulties experienced from lack of transport, fear of risky 
surroundings, unfavourable weather conditions (Serour et al, 2007), waiting in long 
queues (Macdonald et al, 2002) and scheduling appointments contribute to the current 
stresses of patients’ lives (Ahluwalia et al, 1997 and JNC7, 2003). 
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2.5.4.2 Complexity of regimes and retaining information 
Complexity of the treatment regimes will affect adherence (Atreja et al, 2005).  Subjects 
retain information short term but methods to retain information long term need to be 
further researched (Cuspidi et al, 2001).  In a South African hospital, a 24 week 
educational programme was shown to be effective in improving subjects’ knowledge on 
hypertension and even more so when telephonic and family support was given (Stewart et 
al, 2005).  However, it was also shown that subjects needed further education every few 
months in order to retain the knowledge (Stewart et al, 2005).  This study by Stewart et al 
(2005) is a randomised controlled study which reveals important information pertinent to 
the current study and which takes place in a similar setting with similar subjects from a 
poor socioeconomic background. 
 
 
2.5.4.3 Medication side effects 
Unfavourable drug side effects and a shortage of drugs may be considered as being 
another reason for poor adherence to treatment (Jokisalo et al 2002, Shaw et al 1995, 
JNC7 2003, and Khalil et al 1997).  Adverse drug effects may be alleviated with 
improved patient-physician communication which will be discussed later (Weingart et al, 
2005).  Weingart et al (2005) show that only two thirds of patients in their study 
discussed symptoms with the doctor and that factors which may influence report-back 
included embarrassment, prior experience and opportunity given to report back about 
adverse effects. 
 
 32
2.5.4.4 Patient perception of health services 
Another reason for non-adherence to treatment regimens in patients with hypertension 
includes problems encountered at health care centres as well as problems related to the 
patients themselves.  Nine out of ten hypertensive patients had identified both health care 
system-related problems and patient-related problems (Jokisalo et al, 2002). Patients who 
perceived problems related to the health care system (such as poor follow-up by health 
centres), were almost four times more likely to be non-adherent. Furthermore, the 
patients perceiving problems related to patients were twice as likely to be non-adherent 
(Jokisalo et al, 2002).   
 
2.5.4.5 Patient knowledge and understanding 
Patient education was shown as ineffective when used alone as an intervention in 
improving adherence to hypertension regimens (Glynn et al, 2010, Hennessy et al 2006 
and Márquez Contreras et al, 2005).  Motivational and multifaceted methods need further 
evidence to support whether they improve treatment adherence (MacDonald et al, 2002).  
Literature shows that limited knowledge on hypertension and health education in general 
negatively affects adherence to treatment regimens (Serour et al, 2007 and Khalil et al, 
1997).  Research has been consistent for a long time in demonstrating that the 
understanding a patient has of their condition is positively correlated to their adherence to 
treatment regimens, and this is related to the amount and type of information given. 
(Atreja et al, 2005, Burgoon et al, 1987 and Hall et al, 1988). 
Adherence may also be confounded by misconceptions leading the patient to adopting 
behaviour which may or may not be beneficial in lowering risk factors.  An example of 
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this is found in Haynes study in 2002 where a patient with diabetes and heart 
complications drank two to three litres of cranberry juice daily due to believing cranberry 
juice assists in preventing heart disease.  The patient was not aware of the effect 
cranberry juice would have on his blood glucose levels (Haynes et al, 2002). 
 
2.5.4.6 Patient attitude and motivation 
Unwillingness to follow advice from the health care professional results in poor 
adherence to treatment regimens (Serour et al, 2007) and patients must be motivated by a 
goal and possess confidence in order to maintain a changed and healthier lifestyle.  
Therefore, it may be important to allow the patient to choose their own goals as this will 
motivate them to reach their goals.  Other stresses and obstacles such as family problems 
or financial pressure will affect adherence negatively (Serour et al, 2007).  Therefore, it is 
important to get other medical allied disciplines involved to ensure the patient is treated 
holistically. (Sol et al, 2008).   
 
2.5.4.7 Patient quality of life 
Poor quality of life also negatively affects adherence to treatment regimens (Serour et al, 
2007).  Patients may not want to express their concerns regarding personal stresses and 
may overestimate their adherence to treatment regimens.  Reasons for overestimation 
could include that patients find it difficult to remember the details of when and how to 
take medication and also that they prefer to please practitioners and therefore want to 
avoid confrontation with health workers (Haynes et al, 2002).  
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2.5.5 Methods to improve adherence to treatment regimes 
2.5.5.1 Reminders 
Calling patients to remind them about treatments and contacting them by telephoning 
them as soon as they do not arrive assists largely in improving adherence to treatment 
regimens.  Patients who miss appointments show the worst form of non-adherence as it is 
the initial sign that they are totally dropping out of treatment.  This procedure may be 
time consuming, but not costly and has proved to be very effective in helping patients 
follow treatment regimens and re-iterates the importance of adherence every time the 
patient visits the institutions (Haynes et al, 2002, Yusuf et al, 2000 and Macharia et al, 
1992).   
According to Park et al (2009), the reasons for the reduction in blood pressure amongst 
other risk factors may include the regular communication with subjects and individually 
tailored programmes which may have motivated the subjects to more eagerly adhere to 
lifestyle modification.  This study and section on reminders was discussed above in more 
detail. 
In short-term regimens (less than 2 weeks), clear instructions must be given to achieve 
adherence to treatments. On the other hand, improving adherence to long-term regimens 
requires organizing information about the regimens and the importance of adhering to it, 
implementing reminders to ensure no missing of appointments (Haynes et al, 2002).  
Heneghan et al (2006) emphasize how reminder packing of medications is a simple and 
effective way of improving adherence to treatment regimens.  According to a review by 
Shroeder et al (2004), successful reminders may include daily drug reminder charts 
 35
(Gabriel et al, 1977), packaging reminders (Skaer et al, 1993), telephone reminders as 
discussed above and electronic medication aid caps (McKenney et al, 1992).  
 
2.5.5.2 Simplifying information 
Patients tend to adhere to treatments which are more convenient and less complex 
(Serour et al, 2007 and Miller et al, 2002).  Therefore, for both lifestyle modification and 
medication-taking, regimens should be practical and fit in with the patient’s normal daily 
activities.  One review shows the most effective method to improve adherence to 
hypertension treatment in patients in an ambulatory setting is by simplifying dosage 
regimens as adherence is affected by the complexity of the treatment regimens (Shroeder 
et al, 2004).  Other methods reviewed included patient education and patient motivation, 
support and reminders which will be discussed separately.  If a treatment requires large 
amounts of time and change, it is most likely it will not be adhered to.  Patients adhere 
better to treatments which coincide well with current lifestyle, routine and belief.  
However, this may frequently occur as a problem as many patients with chronic diseases 
often require huge lifestyle modification as opposed to changing one or two lifestyle 
aspects.  (Haynes et al, 2002, Miller et al, 2006 and Atreja et al, 2005).  This may also 
create feelings of negativity towards themselves, the regimens and the health professional 
which ultimately results in further non-adherence.  This may be solved by ensuring that 
treatment regimens are recorded in a simplified yet attractive manner in order to create 
feelings of positivity and self-efficacy towards the treatment (Haynes et al, 2002). 
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2.5.5.3 Physician-patient communication 
It is important to listen to the patient’s problem before trying to come up with a 
management strategy.  Previous studies show that physicians interrupt their patients on 
average 18 seconds after they have begun talking (Beckman and Frankel, 1984).  Many 
patients also do not always disclose all the necessary information to physicians due to 
poor patient-physician relationships.  In addition to this, cultural differences and language 
barriers may contribute to further communication problems.  This occurs especially in 
minority and multicultural populations (Park et al, 2009, Weingart et al, 2005, Betancourt 
et al, 1999).  Sound communication between the patient and the health care team results 
in improved adherence to regimens and poor communication results in poor adherence 
and outcome (Burnier et al, 2000 and Barrier et al, 2003).  Barrier et al (2003), discusses 
how two words ‘What else?’ can improve physician-patient communication.   
Three aspects of a medical interview are gathering information, building a relationship 
and educating the patient and these occur concurrently.   
1. Gathering information should be patient-centred and the patient should be allowed 
and encouraged to share all problems to gain a holistic understanding instead of 
interrupting the patient after the first complaint.  Once patients have finished 
expressing their problems, it is important for the physician to summarize the 
problems back to the patient in order to show and ensure physician understanding. 
2. Building relationships involves being aware of verbal and non-verbal cues the 
patient is giving.  The mnemonic PEARLS assists in relationship building: 
Partnership (the patient is not alone in this), Empathy (physician understands 
what the patient is going through), Apology (physician is apologetic for the 
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patient’s inconveniences such as long queues), Respect (for the patient’s 
struggles), Legitimization (recognizes that the frustration is representative of 
many) and Support (the physician will not desert the patient).   
3. Educating the patient involves identifying their current perspective in order to 
gain knowledge on how to individually improve those perspectives for improved 
adherence and results (Barrier et al, 2003). 
 
2.5.5.4 Patient-practitioner relationship 
The practitioner-patient relationship is of the utmost importance as it is necessary to 
understand the complexity of the patients’ personal characteristics, social, psychological 
and cultural background in order to improve patient adherence to treatment regimens.  It 
is important for the practitioner to remember that patients are not clients, but rather 
complex beings who have consulted them in a personal manner.  Issuing or instructing a 
patient to follow treatment regimens will often result in poor adherence but discussing 
with the patient treatment that best suits the patients’ social, psychological, cultural and 
personal lifestyle will result in improved and sustained adherence to treatment regimens.  
This may be time-consuming but will save time when considering long-term application 
as patients will adhere to treatment regimens better and in turn, will not need consultation 
as regularly due to a decrease in complications and improved health status (Lutfey and 
Wishner, 1999 and Atreja et al, 2005). This challenges us to take time to investigate 
patients’ belief, traditions and cultures when attempting to implement interventions for 
lifestyle modification as knowledge in itself will not be effective (Miller et al, 2002).   
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2.5.5.5 Shared decision-making 
In the past, patients had very little part in deciding the treatment regimes they would need 
to adhere to.  In a study by Davis et al (2003), shared decision-making and risk 
communication resulted in better understanding of the decisions made.  This would need 
to be further researched to find whether these methods of shared decision-making and 
risk communication help patients adhere better to treatment.  This would assumingly 
seem to be true, as patients have a better knowledge and understanding of their condition 
when it is explained to them, resulting in adherence to regimes due to their ‘perceived 
benefit’.  In this study, some subjects felt they gained better understanding of their 
condition than in usual consultations.  In addition to the above, it is ethically acceptable 
to involve patients in decision-making processes as opposed to the previous approach 
where the health care professional made all the decisions.  Shared decision-making is 
difficult to implement.  The shared decision-making (SDM) model integrates four 
strategies to overcome this difficulty through approaching patients diseases differently 
and coming to terms with living with chronic illness, communicating with the patient in 
terms of the difficulties they encounter and are not managing successfully, then reflecting 
mutually on these difficulties and gaining shared understanding of the difficulties and 
lastly encouraging independent reflection in order for patients to solve the problems 
(Zoffman et al, 2008).  Communication is therefore of the utmost importance in assisting 
patients to adhere to treatment regimens.  Information about hypertension and the 
treatment thereof determines patient motivation and understanding (Jokisalo et al, 2002).  
This gives the patient purpose and helps them to see the importance of adherence to 
treatment.  
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2.5.5.6 Family/spousal support 
Improving adherence to long-term regimens requires ensuring support from family and 
friends and giving rewards or recognizing patients for efforts to adhere to treatment.  
(Haynes et al, 2002).  Support is key in improving adherence to behaviour modification.  
It may be important to get the family involved for extra support, if the patient consents to 
this (Miller et al, 2002).  It has been found that strong social support contributes to the 
initiation of weight loss and maintenance thereof (Burke et al 2009, Wilde and Garvin, 
2007 and Verheijden et al, 2005).  Social support can be divided into two aspects namely 
structural and functional.  Structural social support refers to the availability of family, 
friends, spouses and groups (Cohen et al, 2000).  Functional social support relies on how 
the patient perceives support and depends on their character and expectation (Cohen et al, 
2000 and Yopp Cohen et al, 1988).  Regular group meetings may also improve adherence 
to self-monitoring programmes (Burke et al, 2009).  Behaviour modification can take 
place when lifestyle information regarding diet, exercise and encouragement is provided 
through social support (Cohen et al, 2000 and Bovbjerg et al, 1995).  Supervised exercise 
programmes used in conjunction with education and telephone calls have shown to 
decrease blood pressure, weight and cholesterol (Gordon et al, 2002) and increase 
adherence to treatment regimes by creating a supportive environment with family, 
healthcare practitioner and patient (Stewart et al, 2005). 
Support can also affect adherence to treatment regimens negatively as it has also been 
shown that, in patients who were not positive towards behaviour modification, spouses 
may have been unhelpful and unsupportive (Burke et al, 2009 and McLean et al, 2003).   
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2.5.5.7 Diaries and self-monitoring methods 
Diaries have been used effectively in medical research and are discussed in detail in this 
section. 
Cohen et al (2005) analyzed diary content from patients and professionals over a 16 
month period in response to implementing interventions for health projects.  Some of 
these interventions included interactive educational programmes based on motivational 
interviewing ; practice protocols to identify overweight and obesity;  goal setting with 
patients;  decision support tools to assist clinicians in providing patient tailored 
counseling and integrated behaviour change from clinicians such as phone calls and 
routine visits.   
Five areas are highlighted in connection with health behaviour change.  Four of these 
areas are discussed below: 
Firstly, patients and practitioners respond well to additional resources or interventions to 
promote lifestyle modification; secondly, support and training from health professionals 
toward patients or each other create positive feelings toward health behaviour change.  
Thirdly, adapting tools and techniques is difficult and time consuming and may not be 
worth it as these resources are valuable.  For example, using web-based programmes may 
be time-consuming without access to fast internet or maintaining telephones and personal 
digital assistants (PDA) could be expensive and unachievable in a public hospital setting 
such as the one used in this study.  Fourthly, changing routines also require changes that 
some health practitioners are not convinced are valuable in improving lifestyle 
modification.  (Cohen et al, 2005).   
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Self-monitoring is another method which may improve adherence to treatment regimens 
(Carels et al, 2005).  Self-monitoring is defined as enhancing self-awareness through self 
examination, regular measurement and recording of intended behaviour (Wilde and 
Garvin, 2007).  Self-monitoring is affected by a person’s feelings, motivation, attitudes 
and propensity toward it (Burke et al, 2009).  Burke et al (2008) shows that adherence to 
self-monitoring deteriorates with time, but there is significant correlation between 
achieved weight loss and the amount of time of self monitoring (Burke et al 2008, Yon et 
al 2007 and Wadden et al 2005). A study by Goldstein et al (1996) compared two 
strategies of teaching, namely, the use of a home monitoring programme- one in a clinical 
setting and another in a Patient Learning Center (PLC).  This study shows that patient 
adherence to a home monitoring programme is 30% greater when taught in a PLC 
compared to a clinical setting.  This may be due to the fact that a PLC provides a 
structured patient educational programme in a quiet, unrushed environment as opposed to 
a clinical setting where noisiness and interruption occur.  Subjects were also able to 
practice the use of the home monitoring programme and attend a free review session to 
ensure they had the skills to effectively use the programme on their own at home.  The 
PLC also allowed for application of individual needs, schedules and personal style of 
learning.  However, this study by Goldstein et al (1996) did have limitations in the fact 
that the sample size appears to be small and a sample size calculation is not evident and 
the study was not truly randomized.  Still, there is valuable information which may assist 
in improving adherence to home monitoring programmes and hereby improving blood 
pressure control.  In order for this to be effective, a quiet and peaceful environment is 
needed to teach patients how to use the programme.  It may be difficult to develop such 
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programmes in the South African setting.  This is because in South African public 
institutions high patient loads daily, long queues and inadequate work space often creates 
a very noisy and busy environment for both staff and patients. 
 
Positives of paper diaries 
Paper diaries may be used to improve adherence to treatment (van Berge Henegouwen, 
1999 and Verbrugge, 1980) by motivating patients as it is a visible reminder and also by 
causing patients to comply as they know it will be reviewed by the physician on the next 
visit.  Arrigo et al (2008) show that, in patients one year post cardiac rehabilitation, using 
a paper diary and three month group sessions almost doubled patients’ adherence to 
exercise compared to patients who did not receive the diary or group sessions.  This was 
found to correlate with adherence to medication-taking and reduction in nicotine usage.  
Verbrugge (1980), in an old study, states that diaries also assist in understanding the 
individual variations in health behaviour of the patient holistically. 
 
Negatives of paper diaries 
However, recording on paper diaries for research purposes is often inaccurate as 
information can be falsified due to “parking lot compliance”.  Parking lot compliance 
occurs when patients sincerely forget to record or may not have the diary at the time 
when recording must take place, which leads to further inaccuracy as patients may record 
retrospectively to make up for missed recordings (Bolger et al, 2003).  This defeats the 
purpose of the diary as it is meant to create changed behaviour at the time of the intended 
recording (Burke et al, 2008 and Bolger et al, 2003).   Without incentives for adherence, 
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recording is often not completed in paper diaries (Hufford et al, 2002, Stone et al, 2003, 
Burke et al, 2008, Verbrugge, 1980 and Burke et al, 2009).   
 
Positives of personal digital assistants 
Personal Digital Assistants (PDA) compared to paper diaries may improve adherence to 
dietary regimens as they can provide instant individualized feedback and reminders to 
encourage compliance (Beasley et al, 2008).   
 
Negatives of personal digital assistants 
However, PDA’s may be difficult and complex to use especially for patients not familiar 
with this technology. Patients should use home monitoring tools which suit their lifestyle 
and skills (Yon et al, 2007).  PDA’s may be difficult to implement on a large scale in 
South Africa as they are expensive and this study was conducted in a first world country 
namely, the USA. 
Subjects using a paper diary compared to an electronic diary have found both easy to use 
and transport (Hufford et al, 2002). 
 
2.6 Conclusion 
In conclusion, health care professionals often underestimate the problem of non-
adherence in their patients.   If a healthcare professional is unable to detect non-
adherence, it is impossible for them to correct the problem.   In this literature review, it is 
shown that the prevalence of hypertension worldwide and locally is problematic.  In 
addition to this, controlling blood pressure in patients with hypertension and other 
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cardiovascular risk factors has proven difficult.  Adherence to medication-taking and 
furthermore lifestyle modification is poor and there are many factors which influence the 
level of adherence to treatment regimens both positively and negatively.  Despite the 
massive amount of literature relating to this topic, further research is necessary to develop 
methods to help patients adopt and maintain these lifestyle interventions.   
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Chapter 3 – Method 
 
 
3.1 Introduction 
  
This chapter describes precisely how the study was performed, what sample size was 
needed, who qualified to take part in the study and how results were analyzed. 
 
3.2 Study Design 
The study design was a quantitative, longitudinal randomized control trial consisting of 
two experimental and one control group. 
 
3.3 Participants 
Participants at the Hypertension Clinic at Helen Joseph Hospital in Johannesburg, South 
Africa were sampled consecutively and then randomized using computer generated 
randomization and concealed allocation.  This was undertaken by the research assistant. 
 
3.3.1 Inclusion criteria  
• Aged 40yrs – 65yrs; 
• Diagnosed with chronic hypertension (defined as blood pressure greater than 140/90 
for more than 24 hours- Brecklin et al, 1998); 
• New patients (at the Hypertension Clinic for the first time). 
 
3.3.2 Exclusion criteria  
• Previous history of severe and prevailing illness/ surgery or disability; 
• Patients on medication other than diabetic & antihypertensive drugs. 
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3.3.3 Sample Size 
In order to measure a blood pressure change of 4-6mmHg SD(±4) at a significance level 
of p=0.05, a sample size of 30 per group was powered at 90% (Stewart et al, 2005). 
Accordingly, the sample size consisted of 90 participants divided equally into 30 control 
participants and 60 experimental participants.  A 15% dropout and 15% non-adherence 
was included in the sample size calculation. 
 
3.3.4 Ethical Consideration 
Ethical clearance was obtained from the Committee for Research on Human  
Participants (Protocol number: M080521).  Clearance form can be found in Appendix A.  
Permission was granted for the study to be done at Helen Joseph Hospital and 
participants were informed of the study (Appendix B) and signed informed consent 
(Appendix C) before participating in the study.  All participants still received the usual 
treatment at the Hypertension Clinic.   
 
3.4 Lifestyle Modification Adherence Tool 
The adherence tool was in the form of a diary (van Berge Henegouwen, 1999 and Arrigo 
et al 2007).  Each day there was new information related to hypertension that was to be 
read, suggestions for specific progressive exercises to do on the day, reminders on what 
to eat and what not to eat (drawn up by the dietician in the clinic according to GDoH, 
healthy eating plan) and a question on whether medication was taken for that day.  A 
column was present on each page to tick when an activity was completed.  Recorded in 
the diary were the dates when the therapist called the participant to follow-up on the 
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progress made (once a month).  Three diary pages are attached (Appendix D) (Soul City 
Magazine). 
 
3.5 Variables / Outcome Measures 
The independent variable was the Lifestyle Modification Adherence Tool (LMAT). 
Dependant variables included blood pressure (primary outcome measure), cholesterol, 
waist-hip ratio, weight and body mass index, glucose level and exercise capacity 
(measured using the standard six minute walk test). 
Demographic data was also collected using a questionnaire on the participant’s first visit.  
These included sex, race, educational level, annual income, cardiovascular risk factors 
and exercise information (Appendix E). 
 
3.5.1 Procedure for measuring blood pressure 
Blood pressure was measured before and immediately after the six minute walk test.  For 
this reason, this is discussed with the procedure for measuring exercise capacity. 
 
3.5.2 Procedure for measuring exercise capacity 
Exercise capacity was measured using the six minute walk test (Borg, 1982 and Guyatt et 
al, 1985).  Participants began the procedure by having their resting blood pressure tested 
in sitting with the left and right arm resting at shoulder height.  A calibrated digital 
sphygnomometer was used to measure blood pressure and heart rate of the participant at 
rest.  A 20m measurement was marked using a tape measure measured against a 
calibrated rod and marked out with beacons on the floor of the hypertension clinic.  The 
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participants were instructed to walk as fast as possible between the beacons for six 
minutes.  If they needed to rest, benches were available next to the measured 20m strip.  
Every 30 seconds, the researcher said “You are doing well, keep it up”.  Immediately 
after the test, participants had their blood pressure and heart rate tested on the left arm 
only and in the sitting position (Borg, 1982).  The normal precautions for exercise testing 
(American College of Sports Medicine, 1991) were taken (see Appendix F).  After the 
test the distance walked and the Rating of Perceived Exertion were measured (Borg, 
1982). 
 
3.5.3 Procedure for measuring waist circumference 
The tape measure was measured against a calibrated 150cm length rod.  A mirror with 
grid lines was placed against a wall.  The grid lines ensured that the tape measure was 
horizontal around the waist and was assessed with a carpenter’s level to ensure that the 
lines were perfectly horizontal. After checking the above, participants were asked to 
remove all clothing around the waist (except very light underwear) and loosen tight 
clothing.  The participants were then asked to stand next to the mirror, feet slightly apart, 
attempting to distribute weight evenly on both feet.  The assessor stood to the side of the 
participant and firmly held the measuring tape around the participants’ waist at the level 
halfway between the lower rib margin and the iliac crest- just above the umbilicus 
(Visscher et al, 2001), making sure the tape was horizontal with the grid lines.  The 
participants were asked to breathe in and out and the measurement was taken when the 
participants had breathed out.  This prevented any inaccurate measurement due to the 
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participants contracting their abdominal muscles or holding their breath.  The 
measurement was recorded to the nearest millimetre. 
 
3.5.4 Procedure for measuring hip circumference 
The preparation and procedure was as for waist circumference except the participants 
removed clothing around the hip and the measurement was taken around the hip at the 
level of the greatest circumference around the buttocks (Visscher et al, 2001). 
 
3.5.5 Procedure for measuring weight 
A digital scale was calibrated.  A carpenter’s level was used to ensure that the floor was 
level.  The participants were asked to remove all clothing, except for light underwear, and 
to step onto the scale with feet slightly apart distributing their weight as evenly as 
possible.  The final reading on the scale was recorded.   
 
3.5.6 Procedure for measuring height 
The wall tape measure was measured using a calibrated 150cm length rod.  A carpenter’s 
level was used to ensure the floor was level.  A weighted string was used to ensure the 
tape measure was vertical against the wall.  The participants were asked to stand relaxed 
with their back against the tape measure on the wall and the height was recorded to the 
nearest millimetre. 
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3.5.7 Procedure for measuring glucose levels 
Glucose and cholesterol were measured in the hospital blood room.  The participants 
were asked to sit on a chair and the laboratory assistant took blood from either the right 
or the left arm. The results were received from the laboratory the next Monday and 
recorded according to the laboratory print-out.  
 
3.6 Familiarization with Outcome Measures 
Prior to undertaking the main study, the researcher familiarised herself with taking all 
measurements and ensuring all precautions as described in section 3.5 above. 
 
3.7 Procedure 
3.7.1 Groups 
The study consisted of three groups, two experimental and one control group. 
All three groups underwent the usual treatment in the Hypertension Clinic.  This 
consisted of a weekly Friday Clinic from 9:00 – 10:00 and involved education about 
hypertension and exercise (given by the physiotherapist at the clinic) and an aerobics 
class lasting 20 minutes with music (by the physiotherapist at the clinic).  Lastly, patients 
were given a chance to ask questions while files were signed.   
 
3.7.1.1 Group 1 (experimental group 1): 
Experimental group one (EG1) received the Lifestyle Modification Adherence Tool as 
well as a once-a-month telephone call from the research assistant.   
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3.7.1.2 Group 2 (experimental group 2): 
Experimental group two (EG2) received only a once-a-month telephone call from the 
research assistant. 
 
3.7.1.3 Group 3 (control group): 
The control group (CG) received the standard treatment at the clinic.   
 
3.7.2 First stage (development of diary) 
Nursing staff were informed of the study and assisted in ensuring new patients were 
referred for assessment.  Research assistants familiarized themselves in the clinic.  The 
adherence tool was developed and prepared by the researcher during this time.   
 
3.7.3 Telephone Call 
Every telephone call to a participant was guided by the same conversation: 
• Greeting 
• How are you doing? 
• How is the medication, diet and exercise programme going? 
• Are you managing to complete and adhere to the daily activities? 
o Are you doing the daily exercises? 
o If not, is there a problem? 
o Are you taking the advice on eating? 
o If not, is there a problem? 
o Are you reading the tips everyday? 
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o If not, is there a problem? 
• Do you have any questions about the medication, diet and exercise programme? 
• Statement of encouragement 
• Statement that if the participant needs to ask any questions, they may phone her (the 
research assistant). 
• End phone call 
 
3.7.4 Second stage (treatment intervention and data collection) 
New participants were sampled consecutively as they arrived in the clinic.  In the 
physiotherapy room the participants were informed about the study and invited to 
participate by the researcher.  If they were willing to participate, they signed informed 
consent (See Appendix C).   
The participants were questioned and then had their blood pressure, weight and body 
mass index, waist-hip ratio, glucose level, cholesterol level and exercise capacity tested 
(as discussed above) by the researcher on the same day of arrival in the clinic.  The 
researcher then recorded the results on a data collection sheet (See Appendix E).   
The research assistant then randomly assigned patients to one of the three groups using a 
process of concealed allocation.  Participants who were in experimental group one (EG1) 
received the LMAT from the research assistant, who explained how to use the diary and 
explained that the diary must not be shared or shown to other patients in the clinic and 
that all questions about the diary must be directed to her only.  The research assistant also 
followed the participants up telephonically once a month for a period of six months (six 
phone calls per patient).  Participants in experimental group two (EG2) received a once a 
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month telephone call only.  A second research assistant was trained to stand-in for the 
research assistant in times when she was not available. 
After six months, variables were measured again (blood pressure, waist-hip ratio, weight 
and body mass index, glucose level, cholesterol level and exercise capacity) by the 
researcher and recorded on a different data collection sheet. The researcher was blinded 
to group allocation and to the results of previous measures.  Participants were blinded to 
results of baseline data.   
A follow-up period of three months with no intervention (patients kept using tool 
independently) took place and the variables were once again measured by the researcher. 
The participants’ files revealed the frequency of check-ups and number of exercise 
classes attended and this was recorded at six months and nine months again. 
 
3.8 Statistical Analysis 
The significance of the study was set at p=0.05.  A Students t-test (independent) was used 
to compare variables between groups at baseline.  The Pearsons Chi Square test was used 
to compare and analyze non parametric data at baseline.   
Change in blood pressure, waist-hip ratio, weight and body mass index, glucose levels 
and exercise capacity between control and intervention groups was established using an 
ANCOVA.   
Pairwise t-tests were used to compare p-values between groups one and two; one and 
three and; two and three. 
STATISTICA was the statistical package used. 
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Chapter 4 – Results 
 
4.1 Introduction 
In this chapter, the results of the differences in demographic data as well as the risk 
factors between the three groups at month 0, month 6 and month 9 are illustrated.  The 
results of weight, body mass index, waist/hip ratio, blood profile, blood pressure and 
distance are explained and a flow diagram is included to illustrate the flow of patients 
through the study. 
 
4.2 Baseline characteristics of participants 
From August 2008 to September 2010, 90 patients, who met the inclusion criteria, signed 
consent to participate in the study.  There were 24 (26.67%) males and 66 (73.33%) 
females.  Concealed randomization resulted in 30 per group, that is, 30 experimental 
group one (EG1) participants, 30 experimental group two (EG2) participants and 30 
control group (CG) participants.  The groups were similar at baseline with regard to age, 
sex, race, annual income, risk factors and exercise intensities and frequencies.  Table 4.2a 
below shows basic demographic characteristics of participants at baseline.   
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Table 4.2a Baseline characteristics of participants (n=90) 
 
The table above shows that most participants’ educational levels were between Grade 8 
and Grade 10 with the majority of these being experimental group 1 participants.  Most 
participants were also not employed or were pensioners, again with the majority of these 
participants being in experimental group 1. 
 
 
 
 
 
 
Characteristics Groups at baseline p-value 
 EG 1 
m (SD) 
EG 2 
m (SD) 
EG 3 
m (SD) 
 
Age 54.8 (±8.75) 53.27 (±9.44) 54.2 (±10.65) 0.71 
 EG 1 
n=30 (%) 
EG 2 
n=30 (%) 
CG 3 
n=30 (%) 
 
Sex 0.41 
• Male 7 (23.33) 6 (20.00) 11 (36.67)  
• Female 23 (76.67) 24 (80.00) 19 (63.33)  
Race 0.69 
• White 4 (13.33) 2 (6.67) 3 (10.00)  
• Black 16 (53.33) 18 (60.00) 18 (60.00)  
• Indian/Coloured 10 (33.33) 10 (33.33) 9 (30.00)  
Educational Level 0.04 
• Grade 7 or less 7 (23.33) 10 (33.33) 11 (36.67)  
• Grade 8–Grade 10 17 (56.67) 6 (20.00) 8 (26.67)  
• Grade 11- Grade 12 5 (5.56) 13 (14.44) 10 (33.33)  
• Tertiary 1 (1.11) 1 (1.11) 1 (1.11)  
Annual Income 0.25 
• ≥ 120 000 1 (3.33) 0 (0.00) 0 (0.00)  
• 80 000 ≤ 120 000 0 (0.00) 1 (3.33) 3 (10.00)  
• 50 000 ≤ 80 000 1 (3.33) 0 (0.00) 0 (0.00)  
• 30 000 ≤ 50 000 4 (13.33) 3 (10.00) 0 (0.00)  
• 20 000 ≤ 30 000 1 (3.33) 2 (6.67) 4 (13.33)  
• 15 000 ≤ 20 000 2 (6.67) 4 (13.33) 6 (20.00)  
• ≤ 15 000 1 (3.33) 4 (13.33) 1 (3.33)  
• Not employed / Pensioner 20 (66.67) 16 (53.33) 16 (53.33)  
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Table 4.2b Baseline cardiovascular risk factors of participants (n=90) 
 
The table above shows that many participants reported the presence of eye problems 
above other risk factors.  Large percentages of participants also reported that they 
exercise, and of these participants, most reported exercising more than five times per 
week, for 30 minutes or more and do a combination of exercises.  This may be due to 
Cardiovascular risk factors Groups at baseline p-value 
 EG 1 
n=30 (%) 
EG 2 
n=30 (%) 
CG 3 
n=30 (%) 
 
Presence of risk factors  
• Stroke 3 (10.00) 5 (16.67) 3 (10.00) 0.78 
• Heart problems 7 (23.33) 9 (30.00) 10 (33.33) 0.77 
• Eye problems 16 (53.33) 20 (66.67) 17 (56.67) 0.64 
• Diabetes 5 (16.67) 6 (20.00) 4 (13.33) 0.94 
• Renal problems 3 (10.00) 1 (3.33) 3 (10.00) 0.69 
• High cholesterol 8 (26.67) 8 (26.67) 7 (23.33) 1.00 
• Smoking 4 (13.33) 2 (6.67) 5 (16.67) 0.61 
• Drinking alcohol 6 (20.00) 5 (16.67) 5 (16.67) 1.00 
• Exercise 23 (76.67) 23 (76.67) 26 (86.67) 0.95 
Number of times exercised per week 0.20 
• Once 3 (13.64) 0 (0.00) 1 (3.85)  
• Twice 3 (13.64) 1 (4.35) 4 (15.38)  
• Three  4 (18.18) 9 (39.13) 7 (26.92)  
• Four  2 (9.09) 3 (13.04) 0 (0.00)  
• Five  1 (4.55) 4 (17.39) 6 (23.08)  
• More than five  9 (40.91) 6 (26.09) 8 (30.77)  
Time spent on exercise 0.81 
• < 10 minutes 3 (13.04) 0 (0.00) 1 (3.85)  
• 10 minutes 1 (4.35) 3 (13.04) 3 (11.54)  
• 15 minutes 3 (13.04) 3 (13.04) 4 (15.38)  
• 20 minutes 3 (13.04) 2 (8.70) 3 (11.54)  
• 30 minutes or more 13 (56.52) 15 (65.22) 15 (57.69)  
Type of exercise 0.13 
• Walking 9 (37.50) 6 (25.00) 13 (50.00)  
• House / Garden work 3 (12.50) 1 (4.17) 4 (15.38)  
• Aerobics 2 (8.33) 1 (4.17) 1 (3.85)  
• Other 0 (0.00) 4 (16.67) 1 (3.85)  
• Combination 10 (41.67) 12 (50.00) 7 (26.92)  
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overestimation discussed in section 2.5.4.7 where patients overestimate adherence to 
regimens in order to please practitioners and avoid confrontation (Haynes et al, 2002). 
 
4.3 Flow of participants through study 
Participants came for assessments at baseline, six months and nine months.  There was a 
dropout of 16 % (n= 15) between month 0 and month 6.  Between month 6 and month 9 
there was only a further 2% (n=2) who dropped out.  Reasons for this included 
participants’ phones not working and therefore not being able to contact them, 
participants moved away from the area or refused re-assessment.  Figure 4.3 
demonstrates the progression of participants through the study. 
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Figure 4.3 Flow of participants through study 
3 dropouts 
• 2 moved to 
another province 
• 1 phone not 
available 
6 dropouts 
• 2 moved to another 
province 
• 2 phones not 
working 
• 1 refused further 
assessment 
Experimental Group 1 
• 6 month adherence diary and once-a-
month telephone call for 6 months 
• And standard treatment 
Experimental Group 2 
• Once-a-month telephone call 
for 6 months 
• And standard treatment 
 
Control Group 
• Standard treatment – this is 
described in Chapter 3 
 
Recorded demographics and measured weight, height, waist-hip, blood pressure and heart rate both 
arms, 6-minute walking test, blood pressure and heart rate post 6-minute walking test only left arm, 
random glucose and cholesterol test 
 
      (n=24)    (n=27)     (n=24) 
 
Subjects meeting inclusion 
and exclusion criteria 
(n=90) 
Recorded demographics and measured weight, height, waist-hip ratio, blood pressure and heart rate 
both arms, 6-minute walking test, blood pressure and heart rate post 6-minute walking test only left 
arm, random glucose and cholesterol test.  Then randomized into three groups 
 
(n=30)        (n=30)    (n=30) 
 
Experimental Group 1 
• Standard treatment continued 
• No intervention 
Month 0 
Month 6 
Month 9 
1 dropout 
• Fractured leg 
6 dropouts 
• 4 phone 
numbers not 
working 
• 2 refused 
assessments 
 
Experimental Group 2 
• Standard treatment continued 
• No intervention 
 
Control Group 
• Standard treatment 
1 dropout 
• Phone not 
working 
Recorded demographics and measured weight, height, waist-hip ratio, blood pressure and heart rate both arms, 
6-minute walking test, blood pressure and heart rate post 6-minute walking test only left arm, random glucose 
and cholesterol test 
(n=23)    (n=27)    (n=23) 
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4.4  Results of Intervention 
Data for variables are presented and tabulated under four headings namely weight, body 
mass index (BMI) and waist/hip ratio; blood profile; blood pressure and; walking 
distance. 
 
4.4.1  Weight, BMI and Waist/Hip ratio 
Table 4.4.1 illustrates the weight, BMI and waist/hip ratio. 
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* Pairwise t-tests revealing significant differences between two groups 
 
 
 
 
 
 
Table 4.4.1.  Mean(SD) of weight, BMI and Waist/hip ratio of groups at month 0, 6 and 9 and the difference between groups at month 0-6 and 
month 0-9 
Outcome Groups Differences between groups 
 Month 0 Month 6 Month 9 Differences between groups 
0 – 6 months 
Differences between groups 
0 – 9 months 
 EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
p-Val 
(p) 
EG1 
m(SD) 
 
EG2 
m(SD) 
CG 
m(SD) 
p-Val 
(p) 
 
Weight 
(kg) 
83.01 
(21.39) 
79.67 
(16.64) 
78.09 
(18.73) 
84.91 
(20.44) 
80.53 
(16.82) 
79.30 
(17.23) 
83.24 
(19.01) 
80.96 
(17.25) 
79.37 
(17.90) 
2.08 
(6.12) 
0.83 
(2.75) 
0.13 
(4.61) 
0.27 2.29 
(7.03) 
1.25 
(2.89) 
-0.02 
(5.41) 
0.32 
BMI 
(kg/h2) 
32.67 
(8.34) 
31.55 
(7.50) 
30.52 
(7.73) 
33.08 
(8.00) 
31.9 
(7.38) 
30.53 
(7.36) 
32.51 
(7.60) 
32.07 
(7.60) 
30.45 
(7.69) 
0.80 
(2.38) 
0.32 
(1.09) 
0.30 
(1.78) 
0.25 0.87 
(2.69) 
0.49 
(1.14) 
-0.02 
(2.12) 
0.30 
Waist/Hip  0.86 
(0.08) 
0.87 
(0.07) 
0.85 
(0.08) 
0.86 
(0.07) 
0.88 
(0.09) 
0.86 
(0.08) 
0.86 
(0.07) 
0.87 
(0.07) 
0.85 
(0.09) 
-0.01 
(0.04) 
0.01 
(0.05) 
0.01 
(0.04) 
0.06 
0.04* 
(1&2) 
0.04* 
(1&3) 
-0.01 
(0.04) 
0.00 
(0.03) 
0.00 
(0.03) 
0.35 
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4.4.1.1 Weight 
There were no statistically significant differences in changes in weight between month 0 
and month 6 (p= 0.27) and between month 0 and month 9 (p= 0.32) between the three 
groups.  Weight increased in all three groups between month 0 and month 6.  Weight, 
therefore, did not improve in any of the groups. 
 
4.4.1.2 BMI 
There were no statistically significant differences in changes in BMI between month 0 
and month 6 (p=0.25) and between month 0 and month 9 (p=0.3) between the three 
groups.  Weight increased in all three groups between month 0 and month 6 and 
decreased only in the control group between month 0 and month 9.   
 
4.4.1.3 Waist/hip ratio 
The pairwise test showed that a significant difference in reduction in waist/hip ratio was 
found between experimental groups 1 and 2 (p=0.04) and between experimental group 1 
and the control group (p=0.04) during month 0 and month 6 (see Table 4.4.1).  This 
change shows that waist/hip ratios decreased in experimental group 1 significantly more 
than the other two groups in the first six months.   
 
4.4.2 Blood profile 
Table 4.4.2 below illustrates the blood profile. 
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*Pairwise t-tests revealing significant differences or trends towards significance between two groups 
 
 
 
 
Table 4.4.2.  Mean(SD) of blood profile of groups at month 0, 6 and 9 and the difference between groups at month 0-6 and month 0-9 
Outcome Groups Difference between groups 
 Month 0 Month 6 Month 9 Differences between 0-6 months Differences between 0-9 months 
 EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
p-Val 
(p) 
 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
p-Val 
(p) 
 
Glucose 
(mmol/l) 
5.50 
(2.24) 
6.22 
(3.48) 
5.58 
(1.78) 
5.23 
(1.21) 
5.95 
(3.19) 
5.26 
(1.14) 
4.82 
(1.15) 
6.13 
(3.20) 
5.13 
(1.15) 
-0.41 
(2.02) 
-0.39 
(3.27) 
-0.15 
(1.12) 
0.71 -0.88 
(2.49) 
0.25 
(2.85) 
0.30 
(1.42) 
0.15 
0.05* 
(1&2) 
Cholesterol 
(mmol/l) 
4.98 
(1.07) 
5.08 
(1.31) 
4.93 
(1.24) 
4.91 
(1.07) 
4.69 
(1.11) 
5.00 
(1.06) 
4.64 
(1.04) 
4.69 
(1.20) 
4.77 
(0.86) 
-0.10 
(0.67) 
-0.37 
(1.09) 
0.10 
(0.94) 
0.19 
0.07* 
(2&3) 
-0.39 
(0.88) 
-0.37 
(0.87) 
0.05 
(0.99) 
0.36 
Triglycerides 
(mmol/l)  
1.55 
(0.65) 
1.65 
(1.23) 
1.32 
(0.53) 
1.58 
(0.63) 
1.53 
(1.06) 
1.54 
(0.82) 
1.56 
(0.74) 
1.58 
(1.08) 
1.18 
(0.60) 
0.02 
(0.36) 
-0.16 
(0.63) 
0.24 
(0.59) 
0.11 
0.04* 
(2&3) 
-0.07 
(0.58) 
-0.12 
(0.57) 
-0.11 
(0.46) 
0.67 
HDL 
(mmol/l) 
1.17 
(0.35) 
1.19 
(0.26) 
1.10 
(0.27) 
1.37 
(1.50) 
1.19 
(0.24) 
1.08 
(0.22) 
1.17 
(0.34) 
1.19 
(0.25) 
1.04 
(0.21) 
0.26 
(1.56) 
-0.01 
(0.16) 
-0.01 
(0.12) 
0.51 0.03 
(0.21) 
0.00 
(0.14) 
0.01 
(0.14) 
0.68 
LDL 
(mmol/l) 
3.10 
(0.88) 
3.11 
(1.06) 
3.01 
(1.04) 
3.42 
(0.80) 
2.78 
(0.85) 
3.20 
(0.84) 
2.74 
(0.76) 
2.73 
(0.77) 
3.20 
(0.67) 
-0.01 
(0.65) 
-0.30 
(0.95) 
0.22 
(0.99) 
0.07 
0.03* 
(2&3) 
-0.39 
(0.83) 
-0.33 
(0.84) 
0.09 
(0.85) 
0.03 
0.02* 
(2&3) 
0.02* 
(1&3) 
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4.4.2.1 Glucose 
There were no statistically significant differences in changes in glucose between month 0 
and month 6 (p=0.71) and between month 0 and month 9 (p=0.15) between the three 
groups.  However, the pairwise test revealed that the glucose levels of experimental group 
1 decreased significantly in comparison to experimental group 2 between month 0 and 
month 9 (p=0.05).   
 
4.4.2.2 Cholesterol 
There were no statistically significant differences in changes in cholesterol between 
month 0 and month 6 (p=0.19) and between month 0 and month 9 (p=0.36) between the 
three groups.  Between month 0 and month 6, however, a pairwise test revealed that 
cholesterol in experimental group 2 decreased, showing a trend towards significance in 
comparison to the control group, whose cholesterol increased (p=0.07).   
 
4.4.2.3 Triglycerides 
A pairwise comparison showed a statistically significant difference between experimental 
group 2 and the control group where experimental group 2 showed a decrease and the 
control group showed an increase in triglycerides (p=0.04) between month 0 and month 
6.  Experimental group 2 was the only group to show decreases in triglycerides between 
month 0 and month 6 but all groups had shown a decrease between month 0 and month 9 
(no significant differences between groups during this period though).   
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4.4.2.4 High density Lipoprotein 
No statistically significant differences in changes were noted between month 0 and month 
6 (p=0.51) and between month 0 and month 9 (p=0.68) between the three groups.  
However, experimental group 1 shows the greatest rise in HDL compared with other 
groups between both month 0 and month 6 and between month 0 and month 9. 
 
4.4.2.5 Low density lipoprotein 
A pairwise comparison shows that LDL was significantly reduced in experimental group 
2 compared with the control group (p=0.03) between month 0 and month 6.  The same 
comparison also shows that LDL was significantly reduced in experimental group 1 
(p=0.02) compared with the control group and between experimental group 2 and the 
control group (p=0.02) between 0 and 9 months.   
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4.4.3 Blood Pressure 
4.4.3.1 Left systolic blood pressure 
See Figure 4.4.3.1 illustrating the left systolic blood pressure over the 9 month period. 
 
Figure 4.4.3.1 Mean left systolic blood pressure of groups over 9 month period 
*Note:  Left systolic blood pressure values at baseline were 142.67mmHg (Group 1), 146.87mmHg (Group 
2) and 140.40mmHg (Group 3); values at month 6 were 135.04mmHg (Group 1), 146.04mmHg (Group 2) 
and 131.13mmHg (Group 3); values at month 9 were 133.65mmHg (Group 1), 137.07mmHg (Group 2) and 
132.78mmHg (Group 3). 
 
There were no statistically significant differences in changes in left systolic blood 
pressure between month 0 and month 6 (p= 0.34) and between month 0 and month 9 (p= 
0.83) between the three groups.  However, left systolic blood pressure decreased in all 
groups between month 0 and month 6 and between month 0 and month 9.  Experimental 
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group 2 shows the largest decrease of 11.08(±28.83) compared with other groups 
between month 0 and month 9.   
 
4.4.3.2 Left diastolic blood pressure 
See Figure 4.4.3.2 illustrating the left diastolic blood pressure over the 9 month period. 
 
Figure 4.4.3.2 Mean left diastolic blood pressure of groups over 9 month period 
*Note:  Left diastolic blood pressure values at baseline were 87.40mmHg (Group 1), 88.03mmHg (Group 
2) and 83.93mmHg (Group 3); values at month 6 were 80.38mmHg (Group 1), 88.70mmHg (Group 2) and 
81.46mmHg (Group 3); values at month 9 were 82.83mmHg (Group 1), 83.41mmHg (Group 2) and 
79.22mmHg (Group 3). 
  
There were no statistically significant changes in differences in left diastolic blood 
pressure between month 0 and month 6 (p=0.26) and between month 0 and month 9 
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(p=0.62) between the three groups.  However, left diastolic blood pressure decreased in 
all groups between month 0 and month 6 with the greatest decrease shown in 
experimental group 1.  All groups also showed a decrease in left diastolic blood pressure 
between month 0 and month 9.  Although left diastolic blood pressure increased between 
month 6 and month 9 in experimental group 1, an overall decrease is noted over the nine 
month period for all three groups.   
 
4.4.3.3 Right systolic blood pressure 
See Figure 4.4.3.3 illustrating the right systolic blood pressure over the 9 month period. 
 
Figure 4.4.3.3 Mean right systolic blood pressure of groups over 9 month period 
*Note:  Right systolic blood pressure values at baseline were 146.04mmHg (Group 1), 149.34mmHg 
(Group 2) and 141.17mmHg (Group 3); values at month 6 were 137.75mmHg (Group 1), 145.26mmHg 
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(Group 2) and 133.33mmHg (Group 3); values at month 9 were 136.43mmHg (Group 1), 137.40mmHg 
(Group 2) and 128.09mmHg (Group 3). 
 
There were no statistically significant changes in differences between groups in right 
systolic blood pressure between month 0 and month 6 (p= 0.76) or between month 0 and 
month 9 (p= 0.37).  All groups showed a decrease in blood pressure though between 
month 0 and month 6 as well as between month 0 and month 9.  
 
4.4.3.4 Right diastolic blood pressure 
See Figure 4.4.3.4 illustrating the right diastolic blood pressure over the 9 month period. 
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Figure 4.4.3.4 Mean right diastolic blood pressure of groups over 9 month period 
*Note:  Right diastolic blood pressure values at baseline were 88.33mmHg (Group 1), 85.22mmHg (Group 
2) and 85.93mmHg (Group 3); values at month 6 were 83.25mmHg (Group 1), 87.04mmHg (Group 2) and 
82.25mmHg (Group 3); values at month 9 were 80.96mmHg (Group 1), 83.28mmHg (Group 2) and 
80.57mmHg (Group 3). 
 
There were no statistically significant changes in differences between groups in right 
diastolic blood pressure between month 0 and month 6 (p= 0.39) and between month 0 
and month 9 (p= 0.83).  However, decreases in right diastolic blood pressure were noted 
in experimental groups 1 and the control group between month 0 and month 6 and in all 
groups between month 0 and month 9.  Once again, experimental group 2 shows the 
greatest decrease between 6 and 9 months in comparison with other groups.  As with the 
 70
previous figures, blood pressure of experimental group 1 has decreased between month 0 
and month 6 but decrease slows between month 6 and month 9, however, still showing 
the greatest overall decrease over nine months as compared to other groups.   
 
4.4.4 Distance walked in the six minute walking test 
Table 4.4.4 illustrates the distance walked in the six minute walk test. 
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Table 4.4.4.  Mean(SD) of distance walked during six minute walk test of groups at month 0, 6 and 9 and the difference between groups at month 0-6 
and month 0-9 
Outcome Groups Difference between groups 
 Month 0 Month 6 Month 9 Differences between 0-6 months Differences between 0-9 months 
 EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
p-Val 
(p) 
 
EG1 
m(SD) 
EG2 
m(SD) 
CG 
m(SD) 
p-Val 
(p) 
 
Distance 
(m) 
462.81 
(65.97) 
446.00 
(101.08) 
472.52 
(65.45) 
453.09 
(93.77) 
473.79 
(74.07) 
469.53 
(113.88) 
473.54 
(66.89) 
471.98 
(66.60) 
479.22 
(74.02) 
-1.17 
(73.40) 
14.57 
(44.51) 
-2.69 
(106.15) 
0.70 19.29 
(44.71) 
12.36 
(41.51) 
1.81 
(63.13) 
0.69 
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There were no statistically significant differences in distance walked between month 0 
and month 6 (p= 0.7) and between month 0 and month 9 (p= 0.69) between the three 
groups.  However, the greatest increase in distance occurred in experimental group 2 
(14.57m) between month 0 and month 6 and in experimental groups 1 (19.29m) and 2 
(12.36m) between month 0 and month 9.  The control group did not show much change 
over the nine month period. 
 
4.5 Conclusion 
These results are now discussed in chapter 6. 
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Chapter 5 – Discussion 
 
5.1 Introduction 
In this chapter, the results of weight, BMI and waist/hip ratio; blood profile; blood 
pressure and, distance walked in the six minute walk test are discussed.  Weight, BMI 
and waist/hip ratio are discussed in terms of eating and exercise habits associated with 
stress, poverty, poor education, time constraints, lack of self control and fast food 
availability.  Glucose, cholesterol, triglycerides and lipoproteins are discussed under 
blood profile.  Blood pressure results are discussed and related to the South African 
Hypertension Guideline 2006 (JNHGWG, 2006) and results of distance walked and the 
six minute walk test (Borg, 1982) are also discussed.  Lastly, telephone call and diary 
reminders are discussed in relation to results obtained. 
 
5.2 Blood Pressure 
Published research shows that it is very difficult to control blood pressure in hypertensive 
patients (Heisler et al 2008, Stewart et al 2005, Alhuwalia et al 1997 Hyman et al 2001 
and Berlowitzet al 1998, Rayner and Schoeman 2009, Philips 2001).  Although changes 
in blood pressure were not significant, reductions in blood pressure were noted in all 
three groups at six and nine months.  The blood pressures of experimental group one 
show the greatest decrease in blood pressure of the three groups in the first six months 
but the decrease slowed between six and nine months and at nine months the group had 
lower blood pressure than at baseline.  The blood pressures of experimental group two 
show minimal change in the first six months but the blood pressures dropped more than 
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the other groups between six and nine months and were also below baseline levels at nine 
months.  Lastly, the blood pressures of the control group showed a decrease in the first 
six months but less than the diary group and then minimal decrease and even a slight 
increase in blood pressure taking place from six to nine months but still resulting in the 
nine month blood pressures being lower than baseline blood pressures.   
 
When comparing the blood pressure results of the three groups with the South African 
Hypertension Guidelines 2006 (JNHGWG, 2006), these blood pressures dropped to 
below the internationally accepted definition of hypertension values (BP ≥ 140/90 
mmHg) and systolic blood pressures dropped by the recommended 4-9mmHg (physical 
activity) and 2-8mmHg (dietary sodium reductions) in all groups except experimental 
group two at six months which only dropped 2.11mmHg (±23.71) (JNHGWG, 2006).  
This is therefore a clinically worthwhile change in blood pressure in all three groups.  In a 
similar way, Stewart et al (2005) also found no significant changes in blood pressure but 
patients were able to modify some cardiovascular risk factors in a supported environment. 
However, the participants in the study done by Stewart et al (2005) were not new to the 
clinic such as the participants in this study. New patients who have not undergone 
treatment in a chronic hypertension unit previously would be expected to respond better 
to treatment than those patients who have been attending the unit for a long period of 
time (JNHGWG, 2006).  Appel et al (2003) showed significant reductions in blood 
pressure when implementing lifestyle modification.  However, the settings and sample 
sizes of the study by Appel et al (2003) cannot be compared with this study as it included 
810 patients from four clinical centres.  Some of the reductions in blood pressure 
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discussed above were large but were not significant due to the large standard deviations 
of these blood pressure measurements.   
The above interpretation suggests that the fact that all patients were new to the clinic and 
being medicated explains the initial drops in blood pressure.  These results may suggest 
that the intervention in experimental group one was effective in the first six months as 
this is when the greatest drops in blood pressure occurred, although these drops were not 
significant.  When the diary intervention was withdrawn after six months, the blood 
pressures reductions slowed down, suggesting that the diary and telephone reminders 
may have had a positive effect.  Experimental group two shows the greatest improvement 
only between six and nine months with smaller change in blood pressures in the first six 
months. This suggests the telephonic reminders may take effect on blood pressure only 
after six months.  The interventions may show a trend of sustained improvement but an 
even longer follow up may be necessary.   
 
Medication did not change in participants unless the participant was experiencing 
unfavourable side effects which occurred in only a few of the participants.   
 
5.3 Weight, BMI and Waist/Hip ratio 
As with this study, research has been consistent in showing that despite implementing 
lifestyle modification it is very difficult to reduce weight and BMI in participants and to 
maintain these changes (Beasley et al 2008, Stewart et al 2005, Shay et al 2009 and 
Burke et al 2009).  The waist/hip ratio in experimental group one was found to be 
significantly reduced compared with other groups.  This is a positive result as waist/hip 
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ratios give an indication of central or abdominal obesity and have been shown to be better 
indicators of cardiovascular disease due to obesity than BMI (Yusuf et al, 2005).  These 
results indicate that the diary and telephone calls in experimental group one may have 
positively influenced the waist/hip ratios and therefore may help in reducing CVD in 
participants such as these. 
Discussed below are eating and exercise habits and the various reasons why it may have 
been difficult to achieve reduction in weight and BMI in participants. 
 
5.2.1 Eating 
Discussed below are possible reasons why eating habits may have prevented participants 
from losing and maintaining healthy weights and BMI. 
 
5.2.1.1 Stress 
Higher stress levels are associated with urbanisation and poor dietary habits (Seedat, 
2000 and Poulter et al, 1985 as cited by Seedat, 2007).  Urban lifestyles can often lead to 
unhealthy eating patterns which worsen hypertension.  Malan et al (2008) show that 
patients have difficulty adjusting from a rural to an urban lifestyle and this change has 
become a cardiometabolic risk.  Despite this, eating correctly is not a priority for people 
when the burden of unemployment, poverty and disease are overwhelming.  Patients seen 
at chronic clinics in public hospitals in South Africa often present with very stressful 
situations.  Patients may present with more than one condition or often have family 
members who are also chronically ill and experiencing the same diagnoses.  This places 
increased levels of stress on patients who are overwhelmed with many problems which 
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they feel they cannot rectify.  In an overview by Bjorntorp (2001), evidence suggests that 
stress is linked to neuroendocrine responses which can result in increased food intake and 
decreased physical activity, leading to abdominal obesity.  Stress is also known to cause 
hypertension (Steyn et al, 2008 and Stewart et al, 2005).  
When considering the above literature, it is worthwhile to attempt reducing stress in 
patients.  It is important to be aware of the stress patients are undergoing and to assist 
them in understanding how important it is to treat the cause of the problem and not the 
symptoms.  Seeing a psychologist and a social worker may help, but can also add further 
stress as it is just one more appointment the patient needs to accommodate.  Stewart et al 
(2005) show that participants with chronic hypertension in an intervention group were 
able to decrease their stress significantly better than control group participants where 
intervention included participants and a family member receiving once a month telephone 
calls as added support.  Patients may feel that added support such as a telephone call may 
help them to reduce stress and know they are cared for. 
 
5.2.1.2 Poverty 
The massive socio-economic problem we face in South Africa affects the eating habits of 
patients.  Studies have shown that hypertensive patients with a low socioeconomic status 
have poorly controlled blood pressure and that blood pressure control increases with 
wealth (Steyn et al, 2008 and Seedat, 2009).  As with this study, Stewart et al (2005) 
show that clinically significant blood pressure change is not achieved and reasons may 
include that most participants were earning less than R15 000 per annum, were 
unemployed or poorly educated.  With many patients being poor and unemployed it 
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becomes difficult to advise on healthy eating, which is often surprisingly expensive to 
maintain.  Stewart et al (2005) also states that poverty in South Africa makes it very 
difficult to choose food wisely.  Patients purchase inexpensive foods which are often high 
in saturated fat and low in protein and nutrients.  The recommended DASH (Dietary 
Approaches to Stop Hypertension) is hindered by poverty and cultural factors (Douglas et 
al, 2003).  There are many children to feed and in the African culture single parents are 
often also caring for children who are not their own.  This obligates a mother to cook 
large amounts of inexpensive and unhealthy food to ensure all are fed.  As a result, 
children become malnourished and obese.  In addition to this, fresh fruit and vegetables 
perish quickly and many people living in informal settlements do not have the means and 
transport to frequently buy such food for themselves and their families or even store such 
food due to their living circumstances.  This results in buying food which is high in 
preservatives and carbohydrate, but low in proteins and vital nutrients needed to maintain 
a healthy body and mind. 
Seedat (2007) states that despite appropriate dietary recommendation, food remains 
inaccessible and unaffordable for poor people in developing countries such as South 
Africa (Seedat, 2007).  Healthy food must be accessible and attainable to all in order to 
prevent and control chronic diseases (JNHGWG, 2006).  Furthermore, fresh foods and 
foods prepared as naturally as possible should be available at inexpensive prices to the 
consumer as these foods require minimal ingredients and labour to prepare and are 
healthier to eat. 
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5.2.1.3 Poor education 
Literature shows that poor education leads to poor blood pressure control (Steyn et al, 
2005 and Steyn et al, 2008).  The majority of participants participating in this study had 
an educational level of Grade 10 or lower.  Poorly educated patients may become obese 
where their knowledge regarding the consequences of obesity and other diseases is 
lacking.  Research has been consistent for a long time in demonstrating that the 
understanding a patient has of their condition is positively related to their adherence to 
treatment regimens, and this is related to the amount and type of information given. 
(Atreja et al, 2005, Burgoon et al, 1987 and Hall et al, 1988).  It is therefore important to 
educate patients regarding obesity and how to lose or manage weight effectively.  
However, as was the case with some participants in this study, patients are generally 
poorly educated and reading and writing or even understanding what is being verbally 
portrayed, may be difficult to achieve.   
 
5.2.1.4 Cultural misconceptions 
Misconceptions may also lead patients to adopting behaviour which may or may not be 
beneficial (Haynes et al, 2002) where knowledge is lacking.  For example, one of the 
participants in this study expressed that obesity in women is an attractive quality to her 
husband and is encouraged in her culture.  Johnson et al (2003) states that obesity in the 
African culture has, for a long time, portrayed an African woman as a good provider, 
wealthy, fertile, voluptuous and prepared for survival in case of food shortage.  Johnson 
et al (2003) also states “In an unpublished interview regarding obesity and African-
American women conducted with African-American men (ages ranging from 45-65) in 
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July 2002, the men all agreed that “real” black men love their women between sizes 14-
20”.  Education on the consequences of such obesity need to be conveyed in an 
appropriate but sensitive manner. 
 
5.2.1.5 Time constraints 
The literature shows that patients do not follow recommended dietary requirements as it 
is difficult to prepare a special diet different from what the rest of the family eats (Serour 
et al, 2007 and Miller et al, 2002).  Healthy eating is often time consuming and 
convenience foods may contain many unhealthy ingredients.  Cooking food from basic 
ingredients is often not done as it is much easier and quicker to buy pre-cooked, tinned 
and processed foods which cook very quickly or can be heated in a microwave.  People 
seem to eat more convenience foods and still have less time which results in a vicious 
cycle of unhealthy living with no time for exercise either.  Urbanisation (Seedat, 2000 
and Poulter et al, 1985) has resulted in busier city lifestyles and buying cheap, unhealthy 
fast food is less time consuming than preparing a meal.   
 
5.2.1.6 Lack of self control 
As discussed previously, it is very difficult for patients to modify lifestyle behaviour and 
sustain such behaviour with enthusiasm (Cobb et al, 2006).  Most patients who are obese 
are used to eating without inhibition.  People often respond to ‘feelings’ and do not stop 
to consider wiser options before consuming the nearest, quickest food option.  
Unfortunately, it seems as if the media play a largely promotive and unhelpful role by 
advertising how good certain (unhealthy) foods make us feel.  Satisfaction is immediate 
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and consequences are not even considered.  Health care professionals must make patients 
aware of false advertising regarding unhealthy foods and educate patients concerning 
helpful outcomes expected with consumption of healthy foods, even if these rewards are 
not immediate.  Diets such as the DASH include varieties of foods which are low in fat 
and high in fibre and are effective in preventing and controlling high blood pressure 
(Miller et al, 2002, Milne and Pinkney Atkinson, 2004, JNHGWG, 2006, Sacks et al, 
2001, Appel et al 2003 and JNC-7, 2003).  However, it is only possible to change 
behaviour if the patient is willing to take responsibility for their own health (Stewart et al, 
2005).  Patients must be willing to exercise self control by choosing healthy foods over 
unhealthy food in order to improve eating habits and in turn, reduce their weight. 
 
5.2.1.7 Wide availability of fast food today 
Fast food is available for most people in South Africa.  This appears to pose a constant 
temptation to individuals who find it hard to weigh up the benefits of buying fresh 
ingredients to cook a healthy meal compared to a quick stop for a meal they would enjoy 
immediately.  At public hospitals in Johannesburg, patients are participanted to trolleys of 
unhealthy snacks and pre-packed fried foods while waiting at the pharmacy for their 
cholesterol medicines!  These foods are very difficult to avoid when patients wait in 
queues for long periods of time and become hungry, tired and frustrated.  Research is 
consistent in finding that the stress of long queues and poor management at healthcare 
facilities must be dealt with in order to improve blood pressure control and change 
cardiovascular risk factors (Stewart et al 2005, Heisler et al 2008 and JNC-7 2008).     
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5.2.2 Exercise 
Exercise was encouraged in participants in all three groups but only discussed 
telephonically with the two experimental groups and included in the Lifestyle 
Modification Adherence Tool (LMAT) of experimental group 1.  This section will be 
discussed in detail under Section 5.5 but below are some reasons why participants may 
not have exercised: 
 
5.2.2.1 Safety and poverty 
Some patients in this study felt unsafe going for walks and did not have the equipment 
they needed to exercise indoors.  Many do not have gardens to work in, live in informal 
settlements and have too many family members to look after to worry about exercising.  
As mentioned previously in section 5.2.1.2, poverty and lack of resource available 
negatively affects adherence to treatment regimens and therefore also prevents patients 
from losing weight, exercising and, in turn, improving blood pressures. 
 
5.2.2.2 Self discipline 
Discussed above in section 5.2.1.5, patients must be willing to discipline themselves to 
exercise.  Behaviour change and therefore, weight loss cannot occur if the patient is not 
willing to make healthier lifestyle choices (Stewart et al, 2005).  However, added support 
and reminders in the form of a telephone call to the participant and a family member once 
a month have been shown to improve exercise capacity (Stewart et al, 2005).   
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5.4 Blood Profile 
5.3.1 Glucose 
Although not significant, reductions in glucose did occur in all groups with the greatest 
reduction occurring in experimental group one.  It is important to remember that all 
groups were exposed to exercise and diet information which forms part of the usual care 
in the clinic, whereas intervention group one possessed a diary with added information on 
eating and exercise.  All participants were new patients to the hypertension clinic and 
may not have previously been educated or exercised and according to the South African 
Hypertension Guidelines 2006 the greatest effect of exercise is seen when patients adapt 
from being sedentary to moderately active (JNHGWG, 2006).  Positively, the diary 
intervention group’s glucose continued to show the greatest drop until nine months which 
indicates that the diary may have had lasting effects.  Mean glucose dropped to normal 
levels in all three groups, but then glucose levels were not exceptionally high at baseline 
(See table 4.3.2). 
 
5.3.2 Cholesterol 
Although not significant, the two experimental groups showed a decrease in cholesterol 
and the control group showed an increase in cholesterol over the first six months.  These 
results highlight the positive trend towards significance shown in both intervention 
groups in reducing hyperlipidaemia by using a diary and receiving a telephone call once a 
month.  However, it is important to note that cholesterol was sustained but did not 
improve in the telephone intervention group between month six and month nine when no 
telephone calls were made.  This suggests the diary is effective during the follow up 
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period after six months as cholesterol continued to drop until nine months, but that the 
telephone group did not improve without the constant telephonic reminders.  As with the 
glucose results, the greatest improvement in cholesterol was noted in experimental group 
one.  Miller et al (2002) also showed a drop in cholesterol due to comprehensive lifestyle 
intervention, although, the cholesterol means were much higher in the study by Miller et 
al (2002) compared to this study. 
 
5.3.3 Triglycerides 
The significant decrease of triglycerides in experimental group two compared with the 
control group at six months could be due to the above factors discussed.  It is unsure why 
experimental group one’s triglycerides did not decrease.  One reason may include that the 
diary group were given dietary guidelines similar to the DASH (Sacks et al, 2001 and 
GDoH healthy eating plan), which is high in carbohydrate and may have prevented a 
reduction in triglycerides in this group whereas this diet was not given specifically to the 
telephone intervention group.  These findings are similar to findings of Miller et al (2002) 
where it is suggested that the reason triglycerides did not decrease or increase 
significantly in the intervention group may be balanced by the consumption of the DASH 
diet and exercise. Braun (2010) states that taking medications alone does not eliminate 
the risk of developing cardiovascular disease and recurrent cardiovascular events.  It is 
important to include lifestyle intervention (healthy eating and physical activity) into  the 
regimes in order to achieve lowered triglyceride and non-HDL cholesterol levels (Braun, 
2010).  It is important to note, however, that triglycerides were not measured in a fasting 
state. 
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5.3.4 HDL and LDL 
Although not significant, the improvement in HDL in experimental group one shows that 
the diary intervention may be effective in raising HDL.  This may be due to the daily 
reminders in the diary to exercise.  This increase was sustained at nine months too.  The 
significant decrease in LDL in experimental group two at six months and both 
intervention groups at nine months also indicates positive change in adherence to the 
diary and telephone reminders especially since an increase is noted in the control groups 
at both six and nine months for LDL.  In a meta-analysis, Kelley et al (2004) showed 
findings similar with decreases in LDL but different with regards to no changes in HDL 
when examining the effect of walking on lipids.  Miller et al (2002) also found significant 
decreases in LDL when implementing a comprehensive lifestyle modification 
programme.  When considering the literature mentioned above, the results of this study 
suggest that the telephone reminders and diary content may have caused this significant 
improvement in LDL in the two intervention groups. 
 
 
5.5 Distance Walked 
Exercise tolerance improved but not significantly in experimental group two at six 
months and in both experimental groups at nine months, showing a trend towards 
significance in both experimental groups.  This suggests that the telephone calls and 
diaries were helpful in promoting regular exercise.  However, in comparison to Stewart et 
al (2005), the distances improved considerably less in this study.  Other studies have also 
shown that home-based exercise programmes improve exercise capacity in patients 
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(Tully, 2005) and self kept diaries of physical activities (Arrigo et al, 2008) and telephone 
calls (Hanssen et al, 2007) improves adherence to exercise.  It is possible that if patients 
had been encouraged more during the six minute walk test, they may have walked 
further.  This is despite having been encouraged to walk as fast as possible at the start of 
the test.  However, the standard protocol of only one encouraging statement per lap was 
followed (Borg, 1982).  Research encourages motivated communication between the 
health care provider and the patient in the form of a trustworthy and empathetic 
relationship.  Motivation improves the control of blood pressure and adherence to 
regimens (Cobb et al, 2006 and JNC-7, 2003).      
 
5.6 Telephone call and diary reminders 
It is shown that patients tend to forget what was said if not constantly reminded (Haynes 
et al, 2002 and Marquez Contreras et al, 2005) and this trend was seen in this study.  The 
telephone calls created a caring and helpful environment.  However, some participants 
also reported avoiding telephone calls and conversation at times when they had not 
adhered to their lifestyle modification programme.  It also gave the participant the 
freedom to understand reasons for non-adherence which were otherwise not possible 
without telephonic communication.  For example, one participant communicated to the 
research assistant that she was not sure she can go on with the LMAT as her husband was 
causing substantial amounts of stress in her home, which hindered her ability to 
effectively follow the LMAT.  The participant did not disclose why this was the case, but 
perhaps time spent on lifestyle modification, food preparation, nature of exercise or even 
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cultural factors as discussed previously played a part in preventing her adherence to the 
intervention.   
In South Africa, it is important to give material in the language spoken at home by the 
patient and family as this will encourage adherence and may also allow the family to 
encourage adherence if the material is well understood.  Perhaps the diary should not only 
have been translated into English and Afrikaans, but also into isiZulu and Setswana too.  
However, an unpublished MSc research report shows that Zulu speaking patients 
preferred to read in English (Grebe, 2009).  This is supported by the JNC-7 which states 
that interventions at public health level are accepted by the community when their 
implementation is diverse in terms of race, culture, religion and social factors (JNC-7, 
2003). 
When looking at the above factors it is important to understand that each patient presents 
with a different reason for not adhering to treatment regimens.  Perhaps it may be 
beneficial to tailor each treatment individually according to the patient as opposed to 
developing one general treatment regime for all.   
Adherence is very difficult to achieve and research has shown this consistently (Haynes 
et al 2002, Heisler et al 2008, Cobb et al 2006, Steyn et al 2008 and Brunenberg et al 
2007) especially in South Africa when considering poor socioeconomic and financial 
implications discussed at length above (Seedat, 2007, Seedat, 2009, Steyn et al, 2001, 
Katz et al, 2009 and Stewart et al, 2005).   
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5.7 Limitations 
The area where the six minute walking test was performed is a very busy and noisy area 
in the clinic, due to it being a thoroughfare to the doctors’ rooms and the cardiac clinic.  
Also, exercise classes with music take place simultaneously.  This may have limited the 
distances walked as there were sometimes patients and staff in the way of the participant 
performing the walking test and the researcher often had to attempt to keep the area clear.  
However, this lack of space is common in public hospitals in South Africa such as the 
one used in this study.  Another limitation includes the few failed blood specimens due to 
incorrect blood samples taken by the laboratory for participants’ blood profile.  This was 
only realized when the results were available a few days after the participants’ blood had 
been taken and participants could not come back to the hospital immediately due to 
reasons pertaining to transport and occupational limitations. 
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Chapter 6 – Conclusion and Recommendations 
 
 
6.1 Conclusion 
Blood pressure did not improve significantly with the implementation of this lifestyle 
modification adherence tool and telephone call or only a telephone call once a month.  
However, there was a positive change in blood pressure, blood profile, waist/hip ratios 
and distances walked with significant changes in intervention groups for triglycerides, 
LDL and waist/hip ratios.  No positive change was noted in weight.   
 
6.2 Clinical Recommendations 
The effectiveness of the LMAT may be improved by asking the participants to bring the 
diary in on each visit for checking or also by including less information in the diary.  
Patients with chronic hypertension must always be referred to the hypertension clinic as 
soon as possible after diagnosis.  Long queues and waiting times need to be reduced to 
improve adherence and prevent the overwhelming situation patients are faced with when 
coming for appointments.  A multi-disciplinary team approach amongst health 
practitioners in the clinic must be adopted in order to optimize patient treatment. 
 
6.3 Recommendations for Future Studies 
The use of short message service (SMS) via cellular phone need to be investigated and 
may assist in furthering knowledge and understanding towards improving adherence in 
patients with chronic hypertension and associated risk factors.  Tailoring specific 
programmes for individual patients to improve adherence may also warrant further 
investigation. 
 90
References 
 
Ahluwalia JS, McNagny SE, Rask KJ. 1997. Correlates of Controlled Hypertension in 
Indigent, Inner-City Hypertensive Patients.  Journal of General Internal Medicine; 12: 7-
14.  Available: www.pubmedcentral.nih.gov [Accessed 15/5/2009] 
 
American College of Sports Medicine. 1991.  Guidelines for exercise testing and 
prescription, 4th ed. Lea and Febiger: Philadelphia, USA [Accessed 02/04/2008]  
 
Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, 
Vollmer WM, Lin PH, Svetkey LP, Stedman SW, Young DR.  2003. Effects of 
Comprehensive lifestyle modification on blood pressure control:  main results of the 
PREMIER clinical trial.  Journal of American Medical Association; 289: 2083-
2093.www.pubmedcentral.nih.gov [Accessed 15/5/2009] 
 
Arrigo I, Brunner-LaRocca H, Lefkovits M, Pfisterer M, Hoffmann A. 2008. 
Comparative outcome one year after formal cardiac rehabilitation: the effects of a 
randomized intervention to improve exercise adherence. European Journal of 
Cardiovascular Prevention and Rehabilitation; 15: 306-311 [Accessed 13/04/2010] 
 
Atreja A, Bellam N, Levy SR, Professor Emeritus. 2005.  Strategies to Enhance Patient 
Adherence: Making it Simple. Medscape General Medicine; 7(1): 4. Available: 
www.ncbi.nlmm.nih.gov/sites/entrez [Accessed 02/04/2008] 
 
Barrier PA, Li JT, Jensen NM. 2003. Two words to improve physician-patient 
communication: what else? Mayo Clinic Proceedings; 78(2):211-4. [Accessed 
13/05/2010] 
 
Beasley JM, Riley WT, Davis A, Singh J. 2008. Evaluation of a PDA-based dietary 
assessment and intervention programme: A randomized controlled trial. Journal of the 
American College of Nutrition; 27(2): 280-286 [Accessed 13/04/2010] 
 
Beckman HB, Frankel RM. 1984. The effect of physician behaviour on the collection of 
data. Annals of Internal Medicine; 101: 692-696. [Accessed 13/05/2010] 
 
Berlowitz D, Ash A, Hickey E, Friedman R, Glickman M, Kader B, Moskowitz M. 1998. 
Inadequate management of blood pressure in a hypertensive population. The New 
England Journal of Medicine; 339:1957–1963. [Accessed 10/05/2010] 
 
Betancourt JR, Carrillo JE, Green AR. 1999. Hypertension in multicultural and minority 
populations: linking communication to compliance. Current Hypertension Reports; 
1(6):482-8. [Accessed 13/05/2010] 
 
Björntorp P. 2001. Do stress reactions cause abdominal obesity and comorbidities?  
Obesity Reveiws;  2: 73-86 [Accessed 6/01/2011] 
 
 91
Bolger N, Davis A, Rafaeli E. 2003. Diary methods: capturing life as it is lived. Annual 
Review of Psychology; 54:579-616. [Accessed 11/05/2010] 
 
Borg GAV. 1982. Psychosocial basis of perceived exertion.  Medicine and Science in 
Sport and Exercise; 14(5): 377-381 [Accessed 02/04/2008] 
 
Bosworth HB, Oddone EZ. 2002. A model of psychosocial and cultural antecedents of 
blood pressure control.  Journal of the National Medical Association; 94(4): 236-48 
[Accessed 13/04/2009] 
 
Bosworth HB, Olsen MK, Neary A, Orr M, Grubber J, Svetkey L, Adams M, Oddone 
EZ.  2008.  Take Control of Your Blood Pressure (TCYB) study:  A multifactorial 
tailored behavioural and educational intervention for achieving blood pressure control.  
Patient Education and Counselling;  70(3): 338-347 [Accessed 13/04/2009] 
 
Bosworth HB, Olsen MK, Oddone EZ. 2005. Improving blood pressure control by 
tailored feedback to patients and clinicians. American Heart Journal; 149(5): 795-803 
[Accessed 13/04/2010] 
 
Bovbjerg VE, McCann BS, Brief DJ, Follette WC, Retzlaff BM, Dowdy AA,Walden CE 
& Knopp RH. 1995.  Spouse support and long-term adherence to lipid-lowering diets. 
American Journal of Epidemiology; 141: 451–460. [Accessed 13/05/2010] 
 
Braun L.  2010.  Cholesterol and Triglyceride Management. “If I take my medication, can 
I eat what I want?”.  Journal of Cardiovascular Nursing;  25(3): 241-246 [Accessed 
6/01/2011] 
 
Brecklin CS, Gopaniuk-Folga A, Kravetz T, Sabah S, Singh A, Arruda JA, Cunea G. 
1998. Prevalence of hypertension in chronic cocaine users.  American Journal of 
Hypertension; 11: 1279-1283 [Accessed 02/04/2008] 
 
Brunenberg D, Wetzels G, Nelemans P, Dirksen C, Severens J, Stoffers H, Schouten J, 
Prins M, de Leeuw P, Joore M.  2007.  Cost Effectiveness of an Adherence-Improving 
Programme in Hypertensive Patients.  Pharmacoeconomics; 25(3): 239-251.  Available:  
www.pubmedcentral.nih.gov [Accessed 15/5/2009] 
 
Burgoon JK, Pfau M, Parrott R, Birk T, Coker R, Burgoon M. 1987. Relational 
communication, satisfaction, compliance gaining strategies and compliance in 
communication between physicians and patients. Communication Monographs; 54:307–
324 [Accessed 16/08/2010] 
 
Burke LE, Sereika SM, Warziski M, Styn MA, Stone A. 2008. Using instrumented paper 
diaries to document self-monitoring patterns in weight loss. Contemporary Clinical 
Trials; 29(2): 182-193. [Accessed 13/04/2010] 
 
 92
Burke LE, Swigart V, Turk MW, Derro N and Ewing LJ. 2009. Experiences of Self-
Monitoring: Successes and Struggles during Treatment for Weight Loss.  Qualitative 
Health Research; 19(6): 815-828 [Accessed 13/04/2010] 
 
Burnier M. 2000. Long-term compliance with antihypertensive therapy: another facet of 
chronotherapeutics in hypertension. Blood Pressure Monitoring; 5:S31-4. [Accessed 
11/05/2010] 
 
Carels RA, Darby LA, Rydin S, Douglass OM, Cacciapaglia HM, O'Brien WH. 2005. 
The relationship between self-monitoring, outcome expectancies, difficulties with eating 
and exercise, and physical activity and weight loss treatment outcomes. Annals of 
Behavioural Medicine; 30(3):182-90. [Accessed 17/05/2010] 
 
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, 
Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, and Blood 
Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment 
of High Blood Pressure; National High Blood Pressure Education Programme 
Coordinating Committee. 2003. The Seventh Report of the Joint National Committee on 
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 
report. Journal of American Medical Association; 289(19):2560-72. [Accessed 
13/05/2010] 
 
Cobb SL, Brown DJ, Davis LL. 2006.  Effective interventions for lifestyle change after 
myocardial infarction or coronary artery revascularization. Journal of the American 
Academy of Nurse Practitioners; 18(1):31-9 [Accessed 26/07/2010] 
 
Cohen DJ, Tallia AF, Crabtree BF, Young DM. 2005.  Implementing Health Behaviour 
Change in Primary Care:  Lessons from Prescription for Health.  Annals of Family 
Medicine; 3(2): s12-s19.  www.pubmedcentral.nih.gov [Accessed 5/10/2009] 
 
Cohen S, Gottlieb BH & Underwood LG. 2000. Social relationships and health. In Social 
Support Measurement and Intervention. A Guide for Health and Social Scientists eds S 
Cohen, LG Underwood & BH Gottlieb, pp 3–25. Oxford: Oxford University Press. 
 
Cramer JA. 1998. Enhancing patient compliance in the elderly. Role of packaging aids 
and monitoring. Drugs Aging; 12:7–15 [Accessed 16/08/2010] 
 
Cuspidi C, Sampieri L, Macca G, Michev I, Fusi V, Salerno M, Severgnini B, Rocanova 
JI, Leonetti G, Zanchetti A. 2001.  Improvement of patients’ knowledge by a single 
educational meeting on hypertension.  Journal of Human Hypertension; 15: 57-61 
[Accessed 02/04/2008] 
 
Daniels A, Biesma R, Otten J, Levitt NS, Steyn K, Martell R, Dick J. 2000.  Ambivalence 
of primary health care professionals towards the South African guidelines for 
hypertension and diabetes. South African Medical Journal; 90(12):1206-11 [Accessed 
26/07/2010] 
 93
Davis R, Dolan G, Thomas S, Atwell C, Mead D, Nehammer S, Moseley L, Edwards A, 
Elwyn G.  2003.  Exploring doctor and patient views about risk communication and 
shared decision-making in the consultation.  Health Expectations; 6: 198-207.  Available:  
www.pubmedcentral.nih.gov[Accessed 15/5/2009] 
 
Douglas J, Bakris G, Epstein M, Ferdinand K, Ferrario C, Flack J, Jamerson K, Jones W, 
Hayward J, Maxey R, Ofili E, Saunders E, Schiffrin E, Sica D, Sowers J, Vidt D, the 
Hypertension in African Americans Working Group.  2003.  Management of high blood 
pressure in African Americans: consensus statement of the Hypertension in African 
American Working Group of the International Society of Hypertension in Blacks.  
Archives of Internal Medicine; 163: 525-541 [Accessed 6/01/2011] 
 
Frohlich ED. 2002. Clinical management of the obese hypertensive patient. Cardiology 
Reviews; 10(3): 127-38 [Accessed 16/08/2010] 
 
Gabriel M, Gagnon JP, Bryan CK. 1977. Improved patient compliance through use of a 
daily drug reminder chart. American Journal of Public Health; 67:968–69. [Accessed 
17/05/2010] 
 
Gauteng Department of Health.  Guide to a healthy eating plan [Accessed 02/04/2008] 
 
Gauteng Department of Health.  Health in Gauteng:  Summary of the Status Report 
2006/2007 [Accessed 02/04/2008]  
 
Gerstein H, Mann J, Yi Q, Sinman B, Dinneen S, Hoogwerf B et al (2001).  Albuminuria 
and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic 
individuals. Journal of the American Medical Association; 286: 421-426 [Accessed 
31/08/2010] 
 
Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. 2010.  Interventions used to 
improve control of blood pressure in patients with hypertension. Cochrane Database of 
Systematic Reviews; 17:CD005182.[Accessed 10/05/2010] 
 
Gohar F, Greenfield S, Beevers DG, Lip GYH, Jolly K. 2008. Self-care and adherence to 
medication: a survey in the hypertension outpatient clinic. BioMed Central 
Complementary Alternative Medicine Journal; 8(4). Available: 
http://www.pubmedcentral.nih.gov [Accessed 16/03/2008] 
 
Goldstein N, Snyder M, Edin C, Lindgren B, Finkelstein S.  1996.  Comparison of two 
teaching strategies:  adherence to a home monitoring programme.  Clinical Nursing 
Research; 5(2):  150-161.  www.wits.ac.za [Accessed 5/10/2009] 
 
Gordis L, Markowitz M, Lillienfeld A. 1969. Studies in the epidemiology and 
preventability of rheumatic fever IV: a quantitative determination of compliance in 
children on oral penicillin prophylaxis. Paediatrics; 43: 173-182 [Accessed 02/04/2010] 
 94
Gordon N, English C, Contractor A, Salmon R, Leighton R, Franklin B, et al. 2002. 
Effectiveness of three models for comprehensive cardiovascular disease risk reduction. 
American Journal of Cardiology; 89: 1263-1267 [Accessed 13/05/2010] 
 
Grebe C. 2009. An investigation into the use of the Oswetry Disability Index in a Zulu 
speaking population: a pilot study (Unpublished MSc research report) 
 
Guidelines Subcommittee.  1999 World Health Organization-International Society of 
Hypertension Guidelines for the Management of Hypertension. Journal of Hypertension; 
17:151-183. [Accessed 10/05/2010] 
 
Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EJ, Pugsley SO, Taylor DW, Berman LB. 
1985. The six minute walk:  A new measure of exercise capacity in patients with chronic 
heart failure.  Canadian Medical Association Journal; 132: 919-923 [Accessed 
02/04//2008] 
 
Hall JA, Roter DL, Katz NR. 1988. Meta-analysis of correlates of provider behaviour in 
medical encounters. Medical Care; 26: 657–675 [Accessed 16/08/2010] 
 
Hanssen TA, Nordrehaug JE, Eide GE, Hanestad BR. 2007. Improving outcome after 
myocardial infarction: a randomized controlled trial evaluating effects of a telephone 
follow-up intervention. European Journal of Cardiovascular Preventative Rehabilitation; 
14: 429-437 [Accessed 1 November 2010] 
 
Haynes RB, McDonald HP,  Garg AX.  2002.  Helping Patients Follow Prescribed 
Treatment Clinical Applications. Journal of the American Medical Association; 288: 
2880-2883.  Available: www.ncbi.nlmm.nih.gov/sites/entrez [Accessed 02/04/2008] 
 
Health Systems Trust. 2006. South African Health Review 2005. Durban. Health System 
Trust 
 
Heisler M, Hogan MM, Hofer TP, Schmittdiel JA, Pladevall M and Kerr EA.  2008.  
When More is not Better:  Treatment Intensification among Hypertensive Patients with 
Poor Medication Adherence.  Circulation.  117: 2884-2892.  
www.pubmedcentral.nih.gov [Accessed 26/10/2009] 
 
Heneghan CJ, Glasziou P, Perera R. 2006. Reminder packaging for improving adherence 
to self-administered long-term medications.  Cochrane Database of Systematic Reviews; 
(1): CD005025 (Abstract) Available: www.ncbi.nlmm.nih.gov/sites/entrez [Accessed 
02/04/2008] 
 
Hennessy S, Leonard C, Yang W, Kimmel S, Townsend R, Wasserstein A.  2006.  
Effectiveness of a two-part educational intervention to improve hypertension control: a 
cluster randomized trial. Pharmacotherapy; 26(9):1342–7.[Accessed 10/05/2010] 
 
 95
Hufford MR, Stone AA, Shiffman S, Schwartz JE, Broderick JE. 2002. Paper vs. 
Electronic Diaries: Compliance and Subject Evaluations. Applied Clinical Trials; 38-43. 
www.actmagazine.com [Accessed 11/05/2010] 
 
Hyman DJ, Pavlik VN. 2001. Characteristics of patients with uncontrolled hypertension 
in the United States. New England Journal of Medicine; 345(7):479–486 [Accessed 
10/05/2010] 
 
Hyman DJ, Pavlik VN. 2000. Self-reported hypertension treatment practices 
among primary care physicians: blood pressure thresholds, drug choices, and the 
role of guidelines and evidence-based medicine. Archives of Internal Medicine; 160: 
2281-6. [Accessed 16/08/2010] 
 
Johnson R, Faan C, Broadnax P.  2003.  A perspective on obesity.  The ABNF Journal; 
May/June: 69-70 [Accessed 6/01/2011] 
 
Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. 2002.  Factors related to non-
compliance with antihypertensive drug therapy.   Journal of Human Hypertension; 16(8): 
577-583. Available: www.ncbi.nlmm.nih.gov/sites/entrez [Accessed 02/04/2008] 
 
Kalk WJ, Veriawa Y, Osler C.  2000.  A survey of hospital outpatient services for chronic 
diseases in Gauteng. South African Medical Journal; 90(1)57-61 [Accessed 26/07/2010] 
 
Katz I, Schneider H, Shezi Z, Mdleleni G, Gerntholtz T, Butler O, Manderson L, Naicker 
S.  2009.  Managing type 2 diabetes in Soweto – The South African Chronic Disease 
Outreach Programme experience.  Primary Care Diabetes; 3: 157-164.  
www.pubmedcentral.nih.gov [Accessed 19/10/2009] 
 
Kelley GA and Kelley KS. 2000. Progressive Resistance Exercise and Resting Blood 
Pressure: A Meta-Analysis of Randomized Controlled Trials. Hypertension; 35: 838-843 
[Accessed 16/08/2010] 
 
Kelley GA, Kelley KS, Tran ZV.  2004.  Walking, lipids and lipoproteins: a meta-
analysis of randomized controlled trials. Preventative Medicine; 38(5): 651-61 [Accessed 
1 November 2010] 
 
Khalil SA, Elzubier AG. 1997. Drug compliance among hypertensive patients in Tabuk, 
Saudi Arabia. Journal of Hypertension; 15: 561–565 [Accessed 11/05/2010] 
 
King JB. 1982. The impact of patients perceptions of high blood pressure on attendance 
at screening, an extension of the Health Belief Model. Social Science and Medicine; 
16(10):1079-91. [Accessed 17/05/2010] 
 
Kirscht JP, Rosenstock IM. 1977. Patient adherence to antihypertensive medical 
regimens. Journal of Community Health; 3(2):115-24. [Accessed 17/05/2010] 
 
 96
Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ, Erdman Jr 
JW, Kris-Etherton P, Goldberg IJ, Kotchen TA, Lichenstein AH, Mitch WE, Mullis R, 
Robinson K, Wylie-Rosett J, Jeor S, Suttie J, Tribble DL, Bazzare TL. 2000. AHA 
Dietary Guidelines: Revision 2000: A Statement for health care professionals from the 
nutrition committee of the American Heart Association. Circulation; 102:22:4 –99 
[Accessed 26/07/2010] 
 
Lawes CMM, Vander Hoorn S, Law MR, et al. 2004.  High blood pressure. In: Ezzati M, 
Lopez AD, Rodgers A, et al, eds. Comparative quanitification of health risks: global and 
regional burden of disease attributable to selected major risk factors.  Geneva: World 
Health Organization, 2004:281-9. [Accessed 10/05/2010] 
Leenen FH, McInnis NH, Fodor G. 2010. Obesity and the Prevalence and Management of 
Hypertension in Ontario, Canada.  American Journal of Hypertension; [Epub ahead of 
print]. [Accessed 10/05/2010] 
Logan A, Milne B, Achber C, Campbell W, Haynes R.  1981.  Cost effectiveness of a 
worksite hypertension treatment programme.  Hypertension; 3: 211-218 [Accessed 
6/01/2011] 
Lutfey KE, Wishner WJ.  1999.  Beyond “Compliance” is “Adherence”. Diabetes Care; 
22(4):635-639. Available: www.pubmedcentral.nih.gov[Accessed 15/5/2009] 
 
Macharia WM, Leon G, Rowe BH, et al. 1992. An overview of interventions to improve 
appointment keeping for medical services. Journal of the American Medical Association; 
267:1813-1817 [Accessed 16/08/2010] 
 
Maheswaran R, Beevers M, Beevers DG. 1992. Effectiveness of advice to reduce alcohol 
consumption in hypertensive patients. Hypertension; 19: 79-84 [Accessed 13/04/2010] 
 
Malan L, Malan NT, Wissing MP, Seedat YK. 2008. Coping with urbanization: a 
cardiometabolic risk? The THUSA study. Biological Psychology; 79: 323-328 [Accessed 
1 November 2010] 
 
Marian L, Neuhouser ML, Miller DL, Kristal AR, Barnett MJ, Cheskin LJ. 2002.  Diet 
and Exercise Habits of Patients with Diabetes, Dyslipidemia, Cardiovascular Disease or 
Hypertension. Journal of the American College of Nutrition; 21(5): 394-401.  Available: 
www.ncbi.nlmm.nih.gov/sites/entrez [Accessed 02/04/2008] 
 
Márquez Contreras E M, Garcia O V, Claros N M, Guillen V G, Wichmann de la Figuera 
von, Martinez J J C.  2005.  Efficacy of telephone and mail intervention in patient 
compliance with antihypertensive drugs in hypertension. ETECUM-HTA study. Blood 
Pressure; 14(3):151–8. [Accessed 10/05/2010] 
 
Mbewu A, President of the Medical Research Council and Professor of Cardiology and 
Internal Medicine, University of Cape Town [Accessed 02/04/2008] 
 97
McDonald HP, Garg AX, Haynes RB. 2002. Interventions to enhance patient adherence 
to medication prescriptions: scientific review. Journal of American Medical Association; 
288(22):2868-79. [Accessed 17/05/2010] 
 
McKenney JM, Munroe WP, Wright JTJr. 1992.  Impact of an electronic medication 
compliance aid on long-term blood pressure control. Journal of Clinical Pharmacology; 
32(3):277–83. [Accessed 17/05/2010] 
 
McLean, N., Griffin, S., Toney, K., & Hardeman, W. 2003. Family involvement in 
weight control, weight maintenance and weight-loss interventions: A systematic review 
of randomized trials. International Journal of Obesity; 27(9): 987-1005. [Accessed 
13/05/2010] 
 
Mensah GA.  2008.  Epidemiology of stroke and high blood pressure in Africa.  Heart; 
94: 697-705. Available: www.pubmedcentral.nih.gov [Accessed 01/11/2009] 
 
Miller ER 3rd, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, 
Appel LJ. 2002. Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-
IT).  Hypertension; 40(5):612-8. Available: www.ncbi.nlmm.nih.gov/sites/entrez 
[Accessed 02/04/2008] 
 
Milne FJ and Pinkney-Atkinson VJ for the Southern African Hypertension Society 
Hypertension Guideline Working Groups 2000 and 2003. 2004. Hypertension Guideline 
2003 Update.  South African Medical Journal;  94(3): 209-225 [Accessed 10/05/2010] 
 
Moore TJ, Alsa beeh N, Apovian CM, Murphy MC, Coffman GA, Cullum-Dugan D, 
Jenkins M, Cabral M.  2008.  Weight, Blood Pressure, and Dietary Benefits after 12 
Months of a Web-based Nutrition Education Programme (DASH for Health): 
Longitudinal Observational Study.  Journal of Medical Internet Research; 10(4): e52.  
Available:  www.pubmedcentral.nih.gov [Accessed 15/5/2009] 
 
Munro S, Lewin S, Swart T, Volmink J. 2007.  A review of health behaviour theories: 
how useful are these for developing interventions to promote long-term medication 
adherence for TB and HIV/AIDS? BMC Public Health; 11(7):104 [Accessed 26/07/2010] 
 
Murray CJ, Lauer JA, Hutubessy RC, Niessen L, Tomijima N, Rodgers A, Lawes CM, 
Evans DB. 2003. Effectiveness and cost of interventions to lower systolic BP and 
cholesterol: a global and regional analysis on reduction of cardiovascular disease risk. 
Lancet; 1(361):717-25 [Accessed 10/05/2010] 
 
Neuhouser ML, Miller DL, Kristal AR, Barnett MJ, Cheskin LJ. 2002.  Diet and Exercise 
Habits of Patients with Diabetes, Dyslipidemia, Cardiovascular Disease or Hypertension. 
Journal of the American College of Nutrition; 21(5): 394-401.  Available: 
www.ncbi.nlmm.nih.gov/sites/entrez [Accessed 02/04/2008] 
 
 98
Park M, Kim H, Kim K.  2009.  Cellular phone and Internet-based individual intervention 
on blood pressure and obesity in obese patients with hypertension.  International Journal 
of Medical Informatics; 78: 704-710.  www.pubmedcentral.nih.gov [Accessed 
19/10/2009] 
 
Phillips L, Branch W, Cook C, Doyle J, El-Kebbi I, Gallina D, Miller C, Ziemer D, 
Barnes C. 2001. Clinical inertia. Annals of Internal Medicine; 135:825–834. [Accessed 
10/05/2010] 
 
Raftery J, Bryant J, Powell J, Kerr C, Hawker S. 2008. Payment to healthcare 
professionals for patient recruitment to trials: systematic review and qualitative study. 
Health Technology Assessment; 12(10):1-128, iii. [Accessed 17/05/2010] 
 
Ramsay LE, Williams B, Johnston G, MacGregor GA, Poston L, Potter JF, Poulter NR, 
Russell G. 1999.  Guidelines for the management of hypertension: report of the third 
working party of the British Hypertension Society. Journal of Human Hypertension; 13: 
569–592. [Accessed 10/05/2010] 
 
Rayner B and Schoeman HS.  2009.   cross-sectional study of blood pressure control in 
hypertensive patients in general practice (the I-TARGET study).  Cardiovascular Journal 
of Africa; 20(4): 224-227. Available: www.pubmedcentral.nih.gov [Accessed 
01/11/2009] 
 
Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzaned E, 
Conlin PR, Miller ER III, Simons-Mortons D, Karanja N and Lin P-H. 2001. Effects on 
blood pressure of reduced dietary sodium and the Dietary Approaches to Stop 
Hypertension (DASH) diet.  DASH-sodium Collaborative Research Group. New English 
Journal of Medicine;135: 1019-1028 [Accessed 16/08/2010] 
 
Saunders LD, Ntoane C, Wilson TD. 1983.  Why don't patients return for 
antihypertensive treatment in Soweto? South African Medical Journal; 64(6):208-10 
(Abstract) Available: www.ncbi.nlmm.nih.gov/sites/entrez [Accessed 02/04/2008] 
 
Seedat YK.  Hypertension in developing countries in sub-Saharan Africa. 2000.    Journal 
of Human Hypertension; 14: 739-747 [Accessed 6/01/2011] 
 
Seedat YK. Impact of poverty on hypertension and cardiovascular disease in sub-Saharan 
Africa. 2007. Cardiovascular Journal of Africa; 18(5): 316-320 [Accessed 1/11/2009] 
 
Seedat YK. 2009. Perspectives on research in hypertension. Cardiovascular Journal of 
Africa; 20(1): 39-42 Available: www.pubmedcentral.nih.gov [Accessed 29/10/2009] 
 
Seedat YK, Croasdale MA, Milne FJ, Opie LH, Pinkney-Atkinson VJ, Rayner BL, 
Veriava Y; Guideline Committee, Southern African Hypertension Society; Directorate: 
Chronic Diseases, Disabilities and Geriatrics, National Department of Health. 2006. 
 99
South African hypertension guideline 2006. South African Medical Journal; 96(4 part 2): 
337-62 [Accessed 26/07/2010] 
 
Seedat YK, Seedat MA, Hackland DB. 1982. Biosocial factors and hypertension in urban 
and rural Zulus. South African Medical Journal; 61: 999-1002 [Accessed 29/10/2009] 
 
Serour M, Alqhenaei H, Al-Saqabi S, Mustafa AR, Ben-Nakhi A. 2007. Cultural factors 
and patients' adherence to lifestyle measures.  British Journal of General Practice; 
57(537):291-5. Available: www.ncbi.nlmm.nih.gov/sites/entrez [Accessed 02/04/2008] 
 
Shaw E, Anderson JG, Maloney M, Jay SJ, Fagan D. 1995.  Factors associated with 
noncompliance of patients taking antihypertensive medications. Hospital Pharmacist; 30: 
201–203, 206–207. [Accessed 11/05/2010] 
 
Shay L, Seibert D, Watts D, Sbrocco T and Pagliara C. 2009. Adherence and weight loss 
outcomes associated with food-exercise diary preference in a military weight 
management programme. Eating behaviours; 10: 220-227 [Accessed 13/4/2010] 
 
Shroeder K, Fahey T, Ebrahim S.  2004. Interventions for improving adherence to 
treatment in patients with high blood pressure in ambulatory settings.  Cochrane 
Database Systematic Review; (2):CD004804 Available: www.pubmedcentral.nih.gov 
[Accessed 1/11/2009] 
 
Skaer TL, Sclar DA, Markowski DJ, Won JKH. 1993. Effect of value added utilities on 
prescription refill compliance and health care expenditures for hypertension. Journal of 
Human Hypertension; 7:515–18 [Accessed 13/05/2010] 
 
Sol B, van der Graaf Y, van der Bijl J, Goessens B, Visseren F. 2008.  The role of self-
efficacy in vascular risk factor management: A randomized controlled trial.  Patient 
Education and Counseling; 71: 191-197.  Available:  
www.pubmedcentral.nih.gov[Accessed 15/5/2009] 
 
Soul City.  Health promotion booklet- Healthy living is good for everyone: High blood 
pressure [Accessed 02/04/2008] 
 
Southern African Hypertension Society Executive Committee 2000. Hypertension 
clinical guideline 2000. South African Medical Journal; 91(2 part 2): 163-172 [Accessed 
16/08/2010] 
 
Stewart A, Noakes T, Eales C, Shepard K, Becker P, Veriawa Y. 2005. Adherence to 
cardiovascular risk factor modification in patients with hypertension.  Cardiovascular 
Journal of South Africa; 16(2): 102-107 [Accessed 02/04/2008] 
 
Steyn K (2007), The Heart and Stroke Foundation of South Africa:  Heart disease in 
South Africa, Medical Research Council, South Africa  [Accessed 15/05/2009] 
 
 100
Steyn K, Bradshaw D, Norman R, Laubscher R.  2008. Determinants and treatment of 
hypertension in South Africans:  The first Demographic and \health Survey.  The South 
African Medical Journal; 98(5): 376-380 Available www.pubmedcentral.nih.gov 
[Accessed 01/11/2009] 
 
Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J.  2001.  Hypertension in South 
African adults: results from the Demographic and Health Survey, 1998.  Journal of 
Hypertension; 19(10): 1717-1725. Available www.pubmedcentral.nih.gov [Accessed 
01/11/2009] 
 
Steyn K, Jooste PL, Bourne L, Fourie J, Badenhorst CJ, Bourne DE, et al. 1991.  
Risk factors for coronary heart disease in the black population of the 
Cape Peninsula. The BRISK study. South African Medical Journal; 79:480-485 
[Accessed 26/07/2010] 
 
Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR.  2003.  Patient 
compliance with paper and electronic diaries. Controlled Clinical Trials; 24(2):182-99. 
[Accessed 11/05/2010] 
 
Tully MA, Cupples ME, Chan WS, McGlade K and Young IS.  2005.  Brisk walking, 
fitness and cardiovascular risk: A randomized controlled trial in primary care.  
Preventative Medicine; 41: 622-628.  www.pubmedcentral.nih.gov [Accessed 
19/10/2009] 
 
Ukena C, Mahfoud F, Kindermann M, Gräber S, Kindermann I, Shneider M, Schmieder 
R, Bramlage P, Volpe M, Thoenes M and Böhm M. 2010. Smoking is associated with a 
high prevalence of microalbuminuria in hypertensive high-risk patients: data from I-
SEARCH. Clinical Research in Cardiology; July 11 [Accessed 25/08/2010] 
 
van Berge Henegouwen MT, van Driel HF, Kasteleijn-Nolst Trenité DG. 1999. A patient 
diary as a tool to improve medicine compliance.Pharmacy World Science; 21(1):21-4. 
[Accessed 17/05/2010] 
 
Verbrugge LM. 1980. Health diaries. Medical Care; 18(1):73-95. [Accessed 17/05/2010] 
 
Verheijden MW, Bakx JC, van Weel C, Koelen MA, van Staveren WA. 2005. Role of 
social support in lifestyle-focused weight management interventions. European Journal 
of Clinical Nutrition; 59 Suppl 1:S179-86. [Accessed 13/05/2010]. 
 
Visscher TLS, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JCM. 2001.  
A comparison of body mass index, weight-hip ratio and waist circumference as predictors 
of all-cause mortality among the elderly: the Rotterdam study.  The International Journal 
of Obesity; 25(11): 1730-1735 [Accessed 13/05/2010] 
Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, Hesson LA, 
Osei SY, Kaplan R, Stunkard AJ. 2005. Randomized trial of lifestyle modification and 
 101
pharmacotherapy for obesity. New England Journal of Medicine; 353(20):2111-20. 
[Accessed 11/05/2010] 
 
Weingart SN, Gandhi TK, Seger AC, Seger DL, Borus J, Burdick E, Leape LL, Bates 
DW. 2005. Patient-reported medication symptoms in primary care. Archives of Internal 
Medicine; 165(2):234-40. [Accessed 17/05/2010] 
 
Whelton SP, Chin A, Xin X, He J. 2002. Effect of aerobic exercise on blood pressure: a 
meta-analysis of randomized, controlled trials. Annals of Internal Medicine; 136 (7): 493-
503 [Accessed 16/08/2010] 
 
Wilde MH & Garvin S. 2007.  A concept analysis of self-monitoring. Journal of 
Advanced Nursing; 57(3): 339–350. [Accessed 13/05/2010] 
 
www.medical.bizcommunity.com/article/196/154/17763.html [Accessed 02/04/2008] 
 
www.who.int [Accessed 13/04/2010] 
 
Yon BA, Johnson RK, Harvey-Berino J, Gold BC, Howard AB. 2007. Personal digital 
assistants are comparable to traditional diaries for dietary self-monitoring during a weight 
loss programme. Journal of Behavioural Medicine; 30(2):165-75. [Accessed 17/05/2010] 
 
Yopp Cohen R. 1988. Mobilizing support for weight loss through work-site competitions. 
In Marshaling Social Support. Formats, Processes, and Effects ed. BH Gottlieb Beverly 
Hills, CA: Sage. Not accessed individually use as cited by??? 
 
Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, 
Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, 
Anand SS; INTERHEART Study Investigators. 2005. Obesity and the risk of myocardial 
infarction in 27,000 participants from 52 countries: a case-control study. Lancet; 366 
(9497): 1640-1649 [Accessed 7/01/2011] 
 
Yusuf S, Sleight P, Pogue J, et al. 2000. Effects of an angiotensin-converting-enzyme 
inhibitor, ramipril, on cardiovascular events in high-risk patients. New England Journal 
of Medicine; 342:145-153 [Accessed 16/08/2010] 
 
Zoffmann V, Harder I and Kirkevold M. 2008.  A Person-Centered Communication and 
Reflection Model: Sharing Decision-Making in Chronic Care. Qualitative Health 
Research; 18: 670-686 [Accessed 13/05/2010] 
 
 
 102
 
Appendices 
